D07AA Corticosteroids, weak (group I)

RX_D07AA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — D07AA 1 out of 7 registries used, show all original rules.	7523
4. Check minimum number of events Min. number of events 3	7523
5. Include endpoints None	7523
6. Filter based on genotype QC (FinnGen only)	7249

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	RX_D07AA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	D07AA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to D07AA Corticosteroids, weak (group I) based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7249	4649	2600
Unadjusted period prevalence (%)	1.48	1.65	1.19
Median age at first event (years)	32.60	27.52	41.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7523: Matched controls
75109

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D07AC14

ATC

methylprednisolone aceponate; topical

5.3

317.9

685

1399

D07AB01

ATC

clobetasone; topical

6.5

314.6

538

883

H02AB06

ATC

prednisolone; systemic

2.5

314.5

3966

23371

D07CC01

ATC

betamethasone and antibiotics; topical

3.5

307.7

1478

4841

E000006, ,

ATC

8.4

307.7

1494

2155

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

31.7

307.7

1089

399

E000001, ,

ATC

10.3

307.7

4491

9470

E000003, ,

ATC

11.5

307.7

1306

1350

S87

ICPC

Dermatitis/atopic eczema

7.0

307.7

587

902

D07AB08

ATC

desonide; topical

8.6

307.7

2581

4295

L20

ICD-10 Finland

Atopic dermatitis

8.8

307.7

1020

1308

R06AE07

ATC

cetirizine; oral

4.5

307.7

5216

25112

R06AX27

ATC

desloratadine; oral

2.8

307.7

3330

16678

E000007, ,

ATC

8.3

307.7

1376

1973

R06AE09

ATC

levocetirizine; oral

3.5

307.7

1971

6931

E0000UV, ,

ATC

15.9

307.7

6576

22797

D11AX15

ATC

[U] pimecrolimus

55.4

307.7

226

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.0

307.7

2072

8505

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

5.1

307.7

2182

5587

D07AA02

ATC

hydrocortisone; topical

+∞

307.7

7523

6287

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.2

307.7

1426

4005

D02AX

ATC

Other emollients and protectives

7.8

307.7

851

1214

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

5.4

307.7

773

1551

N05BB01

ATC

hydroxyzine; systemic

9.0

307.7

1626

2234

D11AH02

ATC

pimecrolimus; topical

36.7

307.7

321

E000002, ,

ATC

10.8

307.7

3198

4798

D07AC13

ATC

mometasone; topical

5.0

307.7

3849

12937

D02AE01

ATC

carbamide; topical

6.1

307.7

1166

2178

S01GX01

ATC

cromoglicic acid; ophthalmic

3.6

307.7

2708

10157

D11AX14

ATC

[U] tacrolimus

63.4

307.7

443

D11AH01

ATC

tacrolimus; topical

33.6

307.7

685

223

D07BA04

ATC

hydrocortisone and antiseptics; topical

9.1

307.7

2835

4682

D07BC01

ATC

betamethasone and antiseptics; topical

3.7

307.7

1373

4232

D07AB02

ATC

hydrocortisone butyrate; topical

6.1

307.7

4367

13880

R06AX13

ATC

loratadine; oral

3.4

307.7

2016

7219

D07AC01

ATC

betamethasone; topical

4.6

307.7

4276

16805

L20.0

ICD-10 Finland

Besnier prurigo

12.1

307.7

3024

3957

R06AX22

ATC

ebastine; oral

3.1

307.7

1943

7619

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

24.8

307.7

470

201

E000004, ,

ATC

9.1

307.7

500

586

D07XB05

ATC

dexamethasone; topical

7.6

307.7

482

670

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

17.9

307.7

474

281

C01CA24

ATC

epinephrine; parenteral

3.9

298.9

971

2734

L27.2

ICD-10 Finland

Dermatitis due to ingested food

8.7

291.0

376

450

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.4

290.3

1215

4042

D07CA01

ATC

hydrocortisone and antibiotics; topical

3.0

276.8

1451

5504

D07XC01

ATC

betamethasone; topical

3.3

275.3

1213

4157

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

11.1

273.8

295

276

D07AD01

ATC

clobetasol; topical

2.7

225.5

1488

6319

R03AC02

ATC

salbutamol; inhalant

2.2

219.7

4665

32257

XQ800

NOMESCO Finland

Prick test

3.1

214.8

993

3473

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

3.2

213.8

958

3289

J01DA01

ATC

[U] cefalexin

2.2

211.9

4885

34645

D09AB01

ATC

zinc bandage without supplements; topical

7.4

209.2

309

432

R03BA02

ATC

budesonide; inhalant

2.4

205.2

1711

8086

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.3

203.8

1915

9537

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

202.4

1719

8185

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

7.3

196.8

293

413

R03DC03

ATC

montelukast; oral

2.4

196.1

1632

7689

D06AX01

ATC

fusidic acid; topical

2.9

194.9

1054

4015

XQ802

NOMESCO Finland

Epicutan test

4.1

192.9

564

1459

S01GX02

ATC

levocabastine; ophthalmic

3.4

184.1

718

2257

R03BA05

ATC

fluticasone; inhalant

2.3

181.1

1786

9020

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.2

179.1

1852

9533

R06AX18

ATC

acrivastine; oral

5.4

173.5

352

676

S01BA01

ATC

dexamethasone; ophthalmic

4.8

169.7

399

870

R03AC03

ATC

terbutaline; inhalant

2.5

168.2

1299

5878

H02AB07

ATC

prednisone; oral

2.6

166.4

1137

4855

J45

ICD-10 Finland

Asthma

2.7

165.8

1027

4179

S01GX08

ATC

ketotifen; ophthalmic

3.5

154.5

575

1749

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

153.2

2875

18231

L26

ICD-10 Finland

Exfoliative dermatitis

34.7

151.8

134

Kela drug reimbursment

General erythroderma

19.4

150.1

117

S01AD03

ATC

aciclovir; ophthalmic

4.2

142.3

389

954

R06AX26

ATC

fexofenadine; oral

2.8

136.7

734

2761

D11AH05

ATC

dupilumab; topical

25.7

135.0

J01DA09

ATC

[U] cefadroxil

1.9

133.4

2155

12874

395

Kela drug reimbursment

Dupilumab

23.8

128.5

L04AA01

ATC

[U] ciclosporin

7.2

128.2

192

272

H02AB04

ATC

methylprednisolone; systemic

2.3

126.6

1116

5301

J01DB01

ATC

cefalexin; oral

2.1

120.9

6238

52631

R01AD09

ATC

mometasone; nasal

1.7

118.0

3607

25923

L20.8

ICD-10 Finland

Other atopic dermatitis

6.1

116.1

203

338

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

115.6

712

2865

L30.3

ICD-10 Finland

Infective dermatitis

3.7

114.9

383

1080

R03BA01

ATC

beclometasone; inhalant

2.2

114.6

1093

5348

R96

ICPC

Asthma

2.5

113.8

819

3549

TQW80

NOMESCO Finland

Local dermatologic skincare

4.4

113.1

291

680

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

112.0

1102

5457

R01AD08

ATC

fluticasone; nasal

1.8

111.9

2272

14447

R01AC01

ATC

cromoglicic acid; nasal

3.2

109.9

457

1483

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.8

102.7

2081

13162

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.7

102.6

336

936

A46

ICD-10 Finland

Erysipelas

2.2

102.3

946

4558

J01FF01

ATC

clindamycin; systemic

1.8

101.7

1940

12044

N05BA01

ATC

diazepam; systemic, rectal

2.2

98.2

975

4829

R03AC12

ATC

salmeterol; inhalant

3.3

94.7

375

1180

N05CD07

ATC

temazepam; oral

2.3

91.2

722

3252

R06AX12

ATC

terfenadine; oral

3.0

90.4

426

1484

N05CF01

ATC

zopiclone; oral

1.7

85.1

2029

13317

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

83.4

1587

9763

R01AD01

ATC

beclometasone; nasal

1.9

83.1

1140

6325

49300

ICD-8 Finland

Asthma, bronchiale

4.2

82.9

223

539

Z51.6

ICD-10 Finland

Desensitization to allergens

4.4

82.1

208

480

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

80.3

780

3814

A06AD11

ATC

lactulose; oral

2.0

79.0

920

4815

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

78.4

488

1964

J45.8

ICD-10 Finland

Mixed asthma

3.4

78.4

293

889

B00.10

ICD-10 Finland

Herpes simplex facialis

6.0

78.2

138

232

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

78.1

1897

12463

D06BB03

ATC

aciclovir; topical

2.9

78.1

396

1435

S01GX09

ATC

olopatadine; ophthalmic

3.3

76.8

300

935

D07CB01

ATC

triamcinolone and antibiotics; topical

4.3

76.2

199

470

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.9

75.5

366

1294

D07XA01

ATC

hydrocortisone; topical

13.0

74.9

D01AC02

ATC

miconazole; topical

2.4

74.8

537

2309

E000005, ,

ATC

30.8

74.6

R06AX11

ATC

astemizole; oral

3.0

72.1

325

1103

R01AD05

ATC

budesonide; nasal

2.3

70.5

584

2672

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.9

70.4

336

1177

N02AX02

ATC

tramadol; systemic, rectal

1.6

69.8

2621

19065

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.3

69.4

142

274

N06AX11

ATC

mirtazapine; oral

1.6

68.9

2308

16342

L04AD01

ATC

ciclosporin; systemic

4.0

68.7

202

521

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

8.7

67.5

J05AB01

ATC

aciclovir; systemic

1.7

66.7

1530

9843

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

66.3

2689

19844

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

66.2

1568

10170

N05BA04

ATC

oxazepam; oral

1.6

66.1

1805

12142

N06AA12

ATC

doxepin; systemic

2.8

65.9

353

1316

S01BA04

ATC

prednisolone; ophthalmic

4.0

65.7

189

480

N05AH04

ATC

quetiapine; oral

1.7

65.0

1419

9000

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

64.5

1813

12272

J46

ICD-10 Finland

Status asthmaticus

3.2

63.8

253

796

Z3231

NOMESCO Finland

Registered nurse

1.6

63.0

1883

12924

R03BB04

ATC

tiotropium bromide; inhalant

2.2

62.9

578

2755

J02AC01

ATC

fluconazole; systemic

1.5

62.6

2805

21083

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

62.5

1709

11474

R03BC01

ATC

cromoglicic acid; inhalant

3.9

61.2

183

478

S01GX06

ATC

emedastine; ophthalmic

4.8

61.1

140

298

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

60.7

777

4183

R03AC13

ATC

formoterol; inhalant

2.6

60.4

362

1428

C03CA01

ATC

furosemide; systemic

1.7

60.2

1436

9303

J30.3

ICD-10 Finland

Other allergic rhinitis

2.6

60.0

365

1450

S29

ICPC

Skin symptom/complaint other

1.7

59.9

1315

8331

R01AD12

ATC

fluticasone furoate; nasal

1.5

59.7

2474

18242

J05AB11

ATC

valaciclovir; oral

1.8

58.8

985

5777

N03AX12

ATC

[U] gabapentin; oral

1.8

58.6

1026

6098

N06AB04

ATC

citalopram; systemic

1.7

58.1

1374

8872

D07XB02

ATC

triamcinolone; topical

4.7

58.0

136

295

R03DA04

ATC

theophylline; systemic, rectal

2.6

57.5

350

1391

J01FA01

ATC

erythromycin; systemic

1.7

57.4

1153

7122

D05AX52

ATC

calcipotriol, combinations; topical

2.5

56.7

381

1586

S01GX05

ATC

lodoxamide; ophthalmic

4.5

56.4

138

310

D07AB09

ATC

triamcinolone; topical

7.2

54.4

114

N06AX21

ATC

duloxetine; oral

1.8

54.3

832

4742

R01AD58

ATC

fluticasone, combinations; nasal

1.5

54.2

1928

13691

N03AX16

ATC

[U] pregabalin

1.6

53.8

1384

9110

R02

ICPC

Shortness of breath/dyspnoea

1.8

53.3

855

4941

E0001A1, ,

ATC

2.9

52.7

253

889

S01GX04

ATC

nedocromil; ophthalmic

3.7

51.9

167

459

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

5.8

51.7

166

D05AX02

ATC

calcipotriol; topical

2.8

51.7

258

926

S21

ICPC

Skin texture symptom/complaint

1.7

50.9

947

5712

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

6.0

50.7

149

R06AE08, ,

ATC

5.0

50.6

110

224

J01FA10

ATC

azithromycin; systemic

1.4

49.8

4360

36736

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

49.6

690

3810

N06AX16

ATC

venlafaxine; oral

1.7

49.5

1079

6792

M02AA07

ATC

piroxicam; topical

1.5

49.0

1968

14290

A02BC01

ATC

omeprazole; systemic

1.5

48.8

1680

11801

J01FA06

ATC

roxithromycin; oral

1.5

48.7

2474

18823

A92

ICPC

Allergy/allergic reaction NOS

2.5

48.4

329

1376

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

48.2

1726

12224

N05AA02

ATC

levomepromazine; systemic

2.6

48.1

298

1194

R01AC02

ATC

levocabastine; nasal

2.8

47.8

248

909

N02BE01

ATC

paracetamol; systemic, rectal

1.6

47.4

6097

55060

A01AB09

ATC

miconazole; local oral

2.0

47.0

569

2997

L28.1

ICD-10 Finland

Prurigo nodularis

6.4

46.7

121

N06AA09

ATC

amitriptyline; systemic

2.0

46.6

543

2822

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

5.3

46.5

176

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

46.5

1658

11720

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.2

46.1

182

571

S02

ICPC

Pruritus

2.4

45.5

317

1341

XQ848

NOMESCO Finland

Dermatological photography

2.9

45.4

211

728

J02AB02

ATC

ketoconazole; oral

2.9

45.1

221

785

A02BC03

ATC

lansoprazole; oral

1.5

44.9

1593

11236

D07AC03

ATC

desoximetasone; topical

3.9

44.9

134

350

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

44.8

530

2769

J02AC02

ATC

itraconazole; systemic

1.6

44.2

1078

6968

J01MA02

ATC

ciprofloxacin; systemic

1.5

44.0

2248

17046

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

44.0

705

4062

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

43.9

1402

9658

A02BC02

ATC

pantoprazole; systemic

1.4

43.8

4178

35358

S97

ICPC

Chronic ulcer skin

2.3

43.7

328

1434

R03BA08

ATC

ciclesonide; inhalant

1.9

43.7

586

3192

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

3.3

43.3

169

527

R01AD11

ATC

triamcinolone; nasal

1.9

41.7

587

3246

R06.0

ICD-10 Finland

Dyspnoea

1.5

41.6

1543

10960

N06AB03

ATC

fluoxetine; oral

1.7

40.8

838

5177

L08.0

ICD-10 Finland

Pyoderma

4.3

40.6

106

251

J30.19

ICD-10 Finland

Pollen allergy UNS

2.1

40.3

385

1859

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

40.2

439

2227

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.9

40.2

119

309

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

4.2

40.2

106

253

J01AA02

ATC

doxycycline; systemic

1.4

40.1

4878

42693

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

8.8

40.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

39.5

795

4882

A07DA03

ATC

loperamide; oral

2.8

39.4

198

713

L04AX03

ATC

methotrexate; systemic

1.8

39.1

628

3617

A02BA02

ATC

ranitidine; systemic

1.6

39.0

1004

6563

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

38.8

2172

16664

D05BB02

ATC

acitretin; oral

3.2

38.8

155

490

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

38.8

2049

15557

N06AX03

ATC

mianserin; oral

2.3

38.7

298

1318

J01XC01

ATC

fusidic acid; systemic

3.9

38.6

113

291

D06BX01

ATC

metronidazole; topical

1.7

37.9

686

4089

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.8

37.9

188

673

J01CF05

ATC

flucloxacillin; systemic

2.0

37.8

433

2233

L17

ICPC

Foot/toe symptom/complaint

1.4

37.7

1801

13411

Z2446

NOMESCO Finland

Social worker

1.9

37.6

542

3019

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.9

37.3

108

276

S18

ICPC

Laceration/cut

1.4

37.1

2669

21342

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

36.9

1211

8358

J01AA07

ATC

tetracycline; systemic

1.6

36.4

1062

7138

N05CF02

ATC

zolpidem; oral

1.6

36.4

1068

7188

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

36.3

1031

6889

A01

ICPC

Pain general/multiple sites

1.8

36.2

577

3314

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

36.0

323

1521

D07AB10

ATC

alclometasone; topical

6.7

36.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

35.6

312

1456

H01.0

ICD-10 Finland

Blepharitis

1.9

35.1

486

2670

S76

ICPC

Skin infection other

2.1

35.1

343

1669

A07AA02

ATC

nystatin; oral

2.1

35.0

331

1591

N02AA05

ATC

oxycodone; systemic

1.6

34.9

829

5306

N07BB01

ATC

disulfiram; oral

2.3

34.5

281

1272

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.1

34.4

145

474

A02BC05

ATC

esomeprazole; systemic

1.4

34.0

2358

18673

Z3226

NOMESCO Finland

Physiotherapist

1.5

33.5

1125

7787

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

33.5

1285

9145

C07AA05

ATC

propranolol; systemic

1.5

33.2

1397

10121

A28

ICPC

Limited function/disability NOS

1.6

33.0

769

4893

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

32.5

204

823

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

32.3

347

1750

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.8

31.9

165

604

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

31.7

525

3047

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

31.7

2071

16205

Z2221

NOMESCO Finland

Medical doctor

1.4

31.6

1763

13433

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.0

31.4

138

462

N05AF03

ATC

chlorprothixene; systemic

2.6

31.3

189

748

XQ830

NOMESCO Finland

Exposure to foodstuff

7.4

31.3

F29

ICPC

Eye symptom/complaint other

1.7

31.2

635

3901

J01MA12

ATC

levofloxacin; systemic

1.5

31.2

958

6499

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

5.5

31.1

110

V01AA05

ATC

tree pollen; parenteral

3.7

31.0

100

276

UJF32

NOMESCO Finland

Coloscopy

1.5

30.8

1332

9684

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

30.7

2666

21776

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

30.5

369

1940

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

4.1

30.3

204

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

30.2

1246

8974

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

30.2

2887

23900

M79.6

ICD-10 Finland

Pain in limb

1.3

30.2

2620

21383

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.0

30.1

315

1573

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

10.0

30.0

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

29.9

287

1387

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

29.8

208

882

WQ000

NOMESCO Finland

Hyposensibilisation

4.0

29.6

212

B00.5

ICD-10 Finland

Herpesviral ocular disease

6.8

29.6

R03BC03

ATC

nedocromil; inhalant

1.9

29.6

386

2080

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

5.6

29.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

29.4

1740

13365

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

29.4

2529

20597

D05AX03

ATC

calcitriol; topical

3.6

29.2

278

E000008, ,

ATC

7.0

29.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

28.9

542

3257

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.1

28.7

123

406

L01

ICD-10 Finland

Impetigo

2.7

28.7

157

592

J01MA14

ATC

moxifloxacin; systemic

1.8

28.7

491

2875

R60.0

ICD-10 Finland

Localized oedema

1.6

28.4

623

3899

P01AB01

ATC

metronidazole; oral, rectal

1.3

28.4

2487

20277

L85.3

ICD-10 Finland

Xerosis cutis

3.8

28.4

223

N05AH03

ATC

olanzapine; systemic

1.8

28.4

450

2576

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

28.4

276

1341

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

28.4

1371

10158

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.1

28.3

116

373

R4110

NOMESCO Finland

Physiotherapy

1.4

28.3

1585

12048

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

28.2

310

1576

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

28.1

917

6292

N03AE01

ATC

clonazepam; systemic

1.9

28.1

339

1779

A01AB04

ATC

amphotericin B; local oral

2.2

28.1

232

1057

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

28.0

482

2826

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

8.8

28.0

N06AB06

ATC

sertraline; oral

1.5

27.8

817

5483

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

27.7

279

1374

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

27.6

5213

47209

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

27.6

2053

16321

505

Kela drug reimbursment

Allergy to cow's milk in infants

6.1

27.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

27.3

861

5865

AA1AD

NOMESCO Finland

CT of head and brain

1.4

27.3

1325

9819

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

27.3

293

1477

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

27.3

443

2555

SPAT1301

SPAT

No procedures

1.4

27.2

1943

15344

R03CC03

ATC

terbutaline; systemic

2.1

27.0

264

1285

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

26.8

118

396

P29

ICPC

Psychological sympt/compl other

1.6

26.8

617

3909

N05AX08

ATC

risperidone; systemic

1.7

26.7

490

2924

S02CA02

ATC

flumetasone and antiinfectives; otic

1.9

26.7

320

1676

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

26.6

3199

27192

L28

ICPC

Limited function/disability (L)

1.5

26.4

846

5782

L29.8

ICD-10 Finland

Other pruritus

3.2

26.3

104

328

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

26.1

356

1945

N05BA02

ATC

chlordiazepoxide; systemic

2.8

26.1

135

495

A02BX02

ATC

sucralfate; oral

2.3

25.7

203

908

SPAT1260

SPAT

Consultation of another employee

1.5

25.7

1071

7710

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

25.6

2611

21667

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

25.5

439

2573

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.1

25.4

173

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

25.4

420

2435

N05BE01

ATC

buspirone; oral

2.3

25.3

193

851

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

25.3

1002

7142

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

25.3

545

3395

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.6

25.2

143

550

L50.9

ICD-10 Finland

Urticaria, unspecified

1.9

25.2

300

1568

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

25.1

741

4972

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

25.1

1189

8761

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.4

25.0

168

700

J01FA09

ATC

clarithromycin; systemic

1.3

25.0

1974

15789

S01AA01

ATC

chloramphenicol; ophthalmic

1.9

25.0

345

1894

-, ,

ICD-10 Finland

2.6

24.9

143

553

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

9.7

24.9

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

24.8

1953

15610

C07AB07

ATC

bisoprolol; oral

1.3

24.8

2300

18820

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

24.8

1597

12384

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

24.7

285

1474

N06AX05

ATC

trazodone; oral

2.3

24.7

181

785

ZY010

NOMESCO Finland

Hospital outpatient

1.7

24.6

420

2456

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

24.6

142

551

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

24.6

561

3545

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

24.4

176

757

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

24.4

473

2864

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

24.4

806

5537

B01AB05

ATC

enoxaparin; parenteral

1.4

24.4

1597

12410

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

24.3

399

2307

M54.5

ICD-10 Finland

Low back pain

1.3

24.3

2272

18600

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

24.2

517

3211

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

24.2

661

4356

M02AA10

ATC

ketoprofen; topical

1.5

24.2

821

5671

L30.0

ICD-10 Finland

Nummular dermatitis

2.1

24.2

225

1076

ZXE00

NOMESCO Finland

One hour or less

1.3

24.1

2439

20177

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.9

24.0

113

394

F03

ICPC

Eye discharge

1.7

24.0

468

2840

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

23.9

258

1303

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

23.9

615

3999

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

23.9

106

358

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

23.8

3661

31944

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

23.8

434

2586

H18.6

ICD-10 Finland

Keratoconus

4.3

23.7

139

J01DA08

ATC

[U] cefaclor

1.4

23.7

1017

7351

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

23.7

1034

7497

F10.24

ICD-10 Finland

Alcohol depence active use

3.1

23.5

100

330

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

23.4

796

5499

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

23.4

201

931

N06AB10

ATC

escitalopram; oral

1.4

23.4

1479

11420

R03CC02

ATC

salbutamol; systemic

1.5

23.3

666

4434

SPAT1310

SPAT

Counselling related to known health issue

1.3

23.3

2056

16679

N03AG01

ATC

valproic acid; systemic, rectal

1.8

23.2

389

2262

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

23.2

207

973

J01CF02

ATC

cloxacillin; systemic

2.7

23.2

126

474

J01DA06

ATC

[U] cefuroxime

1.5

23.2

841

5885

E66.8

ICD-10 Finland

Other obesity

1.8

23.1

373

2146

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

23.1

813

5656

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

23.0

147

599

SPAT1229

SPAT

Assessment of need for aid

1.8

22.9

359

2047

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

22.9

166

717

N06AX12

ATC

bupropion; oral

1.6

22.8

556

3567

K02.1

ICD-10 Finland

Caries of dentine

1.3

22.8

4220

37585

M48.0

ICD-10 Finland

Spinal stenosis

1.6

22.7

502

3145

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

3.7

22.7

188

M04AA01

ATC

allopurinol; systemic

1.6

22.7

531

3375

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

22.6

2367

19630

N03AF01

ATC

carbamazepine; oral, rectal

2.0

22.6

265

1379

D01AC03

ATC

econazole; topical

1.8

22.5

314

1729

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

22.5

2038

16578

EBA00

NOMESCO Finland

Extraction of tooth

1.3

22.4

2459

20514

C03DA01

ATC

spironolactone; oral

1.6

22.4

539

3448

N02BF01

ATC

gabapentin; oral

1.7

22.3

450

2753

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

22.3

319

1770

D01AE15

ATC

terbinafine; topical

1.8

22.3

358

2057

KMAK, ,

NOMESCO Finland

1.3

22.3

3452

30053

N05CD02

ATC

nitrazepam; oral

3.1

22.3

288

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

22.2

1139

8492

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

22.1

520

3307

N03AX09

ATC

lamotrigine; oral

1.8

22.1

371

2159

H03.1

ICD-10 Finland

Involvement of eyelid in other infectious diseases classified elsewhere

7.9

22.1

WIX00

NOMESCO Finland

Allergy cleanup guidance

9.0

22.0

A03FA02

ATC

cisapride; oral, rectal

1.7

22.0

379

2222

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

22.0

971

7053

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

21.9

526

3363

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

3.4

21.9

231

D01AC08

ATC

ketoconazole; topical

3.1

21.7

287

Z71.8

ICD-10 Finland

Other specified counselling

1.3

21.7

2111

17320

ZXD05

NOMESCO Finland

Urgent procedure

1.3

21.5

1889

15278

L03

ICPC

Low back symptom/complaint

1.3

21.4

1736

13884

WZC30

NOMESCO Finland

Teaching

1.5

21.4

813

5738

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

21.4

1515

11883

S06

ICPC

Rash localized

1.8

21.2

333

1900

ZXA05

NOMESCO Finland

Left side

1.4

21.1

1207

9155

J01EA01

ATC

trimethoprim; systemic

1.3

21.1

1556

12272

N05AB01

ATC

dixyrazine; systemic

3.5

21.1

212

50708

ICD-8 Finland

Hay fever, Alia definita

5.4

21.1

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

21.1

4952

45177

P76

ICPC

Depressive disorder

1.6

21.1

514

3298

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.2

21.0

267

D01AA02

ATC

natamycin; topical

2.4

21.0

138

570

S84

ICPC

Impetigo

3.6

21.0

189

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

20.9

117

448

N02BF02

ATC

pregabalin; oral

1.8

20.9

339

1955

R03DC01

ATC

zafirlukast; oral

2.9

20.8

326

S88

ICPC

Dermatitis contact/allergic

2.4

20.8

149

640

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

2.9

20.7

327

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.8

20.7

L60.0

ICD-10 Finland

Ingrowing nail

1.8

20.7

308

1730

S01

ICPC

Pain/tenderness of skin

1.9

20.7

280

1527

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

20.7

515

3321

R05

ICPC

Cough

1.3

20.6

1545

12211

R97

ICPC

Allergic rhinitis

2.1

20.5

183

861

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.3

20.5

125

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

20.5

1058

7887

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

20.5

2808

24008

N05AA01

ATC

chlorpromazine; systemic, rectal

3.2

20.5

261

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

20.5

1008

7456

F34.1

ICD-10 Finland

Dysthymia

1.9

20.4

255

1355

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

20.4

2598

22011

R53

ICD-10 Finland

Malaise and fatigue

1.3

20.4

1516

11962

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

20.4

229

1174

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

20.4

5005

45795

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

20.4

488

3117

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.3

20.3

227

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

20.3

168

767

SPAT1058

SPAT

PEF monitoring instruction

1.6

20.3

450

2820

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

20.3

444

2774

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

20.3

142

604

A06AC51

ATC

ispaghula, combinations; oral

1.9

20.3

259

1387

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

3.7

20.3

175

SPAT1325

SPAT

Vaccination

1.3

20.2

1922

15689

SPAT1254

SPAT

Administration of medicine

1.4

20.2

921

6718

D12

ICPC

Constipation

2.1

20.2

201

986

N02AC04

ATC

dextropropoxyphene; oral

2.2

20.2

164

744

R05DB05

ATC

pentoxyverine; oral, rectal

2.1

20.1

194

941

G44.2

ICD-10 Finland

Tension-type headache

1.4

20.1

882

6390

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

20.1

2185

18146

P01

ICPC

Feeling anxious/nervous/tense

1.4

20.1

1099

8274

D05AA

ATC

Tars

4.3

20.0

119

P15

ICPC

Chronic alcohol abuse

2.1

20.0

182

863

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

20.0

490

3146

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

19.9

269

1466

A04

ICPC

Weakness/tiredness general

1.4

19.9

977

7222

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

19.8

473

3018

A10BA02

ATC

metformin; oral

1.4

19.8

1283

9919

U07

ICPC

Urine symptom/complaint other

1.7

19.8

388

2358

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

19.7

286

1596

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

19.6

749

5289

W19

ICD-10 Finland

Unspecified fall

1.5

19.6

564

3758

WXQ24

NOMESCO Finland

UVB/UVA light therapy

28.9

19.6

S06.0

ICD-10 Finland

Concussion

1.5

19.6

697

4855

M01AH01

ATC

celecoxib; oral

1.4

19.5

846

6116

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

19.5

531

3495

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

19.5

569

3804

R50.9

ICD-10 Finland

Fever, unspecified

1.4

19.4

960

7102

L50.0

ICD-10 Finland

Allergic urticaria

2.0

19.4

198

982

K08.3

ICD-10 Finland

Retained dental root

1.7

19.3

370

2234

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

19.3

2464

20849

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

19.3

239

1268

SPAT1240

SPAT

Therapeutic discussion

1.4

19.2

832

6012

R52.2

ICD-10 Finland

Other chronic pain

2.0

19.2

218

1122

L12

ICPC

Hand/finger symptom/complaint

1.4

19.2

1036

7777

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.1

19.2

251

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

19.1

873

6371

H01

ICPC

Ear pain/earache

1.4

19.1

867

6320

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

19.0

158

723

N06AA06

ATC

trimipramine; systemic

2.3

19.0

137

591

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.5

19.0

183

N07BA03

ATC

varenicline; oral

1.8

18.8

284

1603

L15

ICPC

Knee symptom/complaint

1.3

18.7

1333

10441

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

18.7

2682

22988

SPAT1255

SPAT

Intravenous administration of medicine

1.7

18.6

351

2110

M79.7

ICD-10 Finland

Fibromyalgia

1.9

18.6

224

1178

P16

ICPC

Acute alcohol abuse

2.5

18.5

114

458

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

18.5

227

1201

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

3.7

18.4

154

P99

ICPC

Psychological disorders other

1.9

18.4

229

1217

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.7

18.3

367

J04AB02

ATC

rifampicin; systemic

3.1

18.2

238

L50.3

ICD-10 Finland

Dermatographic urticaria

2.3

18.1

133

578

N05AB03

ATC

perphenazine; systemic, rectal

2.0

18.1

205

1055

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

18.0

139

618

SPAT1263

SPAT

Sampling

1.2

18.0

2714

23364

T82

ICPC

Obesity

1.8

17.9

268

1509

SFA10

NOMESCO Finland

One-surface restoration

1.2

17.9

3774

33689

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

17.9

535

3593

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

17.9

297

1724

L21.0

ICD-10 Finland

Seborrhoea capitis

3.0

17.8

262

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

17.8

188

944

S01XA02

ATC

retinol; ophthalmic

5.1

17.8

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

2.8

17.8

300

B00.11

ICD-10 Finland

Herpes simplex labialis

2.3

17.6

127

548

L30.8

ICD-10 Finland

Other specified dermatitis

2.1

17.5

166

801

C05AA08

ATC

fluocortolone; rectal, topical

1.5

17.5

660

4645

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

17.5

1333

10530

A10BJ06

ATC

semaglutide; parenteral

1.8

17.5

241

1323

S01AA13

ATC

fusidic acid; ophthalmic

1.9

17.5

226

1216

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

17.4

335

2026

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.3

17.4

199

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.3

17.4

132

583

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.6

17.3

156

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

20.9

17.2

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

17.2

1121

8653

D01BA02

ATC

terbinafine; oral

1.3

17.2

1257

9867

S01AX11

ATC

[U] ofloxacin

2.0

17.2

180

901

J20

ICD-10 Finland

Acute bronchitis

1.5

17.2

575

3952

R51.80

ICD-10 Finland

Headache

1.4

17.2

1070

8206

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.2

17.1

142

650

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.8

17.1

312

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.0

17.1

173

856

V03AA01, ,

ATC

2.9

17.0

269

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.6

17.0

153

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

16.9

321

1934

B00.0

ICD-10 Finland

Eczema herpeticum

3.7

16.9

140

N05AD01

ATC

haloperidol; systemic

2.1

16.9

159

766

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

16.9

1531

12379

A02BA03

ATC

famotidine; systemic

2.1

16.8

164

800

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

16.8

483

3215

R05DB20

ATC

other cough suppressants - combinations

1.7

16.8

329

1998

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

16.8

576

3981

R03BB01

ATC

ipratropium bromide; inhalant

2.0

16.7

175

876

WQ064, ,

NOMESCO Finland

63.4

16.7

M03BX02

ATC

tizanidine; oral

1.2

16.7

3801

34098

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

16.7

409

2628

R52.9

ICD-10 Finland

Pain, unspecified

1.5

16.7

551

3779

H02AB09

ATC

hydrocortisone; systemic

2.0

16.6

170

844

L01BC59

ATC

trifluridine, combinations; systemic

6.4

16.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

16.6

556

3825

N06AA10

ATC

nortriptyline; systemic

2.3

16.5

124

545

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

16.4

488

3273

N04AA02

ATC

biperiden; systemic

2.4

16.4

110

460

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

16.3

842

6263

S71

ICPC

Herpes simplex

3.2

16.3

207

J01CA04

ATC

amoxicillin; systemic

1.3

16.3

5965

56266

-50

ICPC

Medication/prescr/renewal

1.9

16.2

214

1160

WX290

NOMESCO Finland

Other blockage of nerve

1.2

16.2

3389

30105

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.2

16.2

193

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

16.1

1496

12121

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

16.1

180

923

J01AA04

ATC

lymecycline; systemic

1.4

16.1

905

6827

G04BD12

ATC

mirabegron; oral

1.5

16.0

465

3102

B05CB01

ATC

sodium chloride; irrigating solution

6.0

16.0

T90

ICPC

Diabetes non-insulin dependent

1.4

16.0

985

7537

S01XA18

ATC

ciclosporin; ophthalmic

3.6

16.0

141

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

16.0

428

2807

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

15.9

3556

31773

L04AX01

ATC

azathioprine; systemic

1.7

15.9

263

1525

L40.8

ICD-10 Finland

Other psoriasis

3.4

15.9

165

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.4

15.9

104

430

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

15.9

621

4398

J01DB05

ATC

cefadroxil; oral

1.8

15.9

256

1475

U04

ICPC

Incontinence urine

1.8

15.9

234

1313

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

15.9

325

S01.0

ICD-10 Finland

Open wound of scalp

1.6

15.8

378

2414

L01

ICPC

Neck symptom/complaint

1.4

15.8

952

7257

S24

ICPC

Hair/scalp symptom/complaint other

2.6

15.8

349

H16.0

ICD-10 Finland

Corneal ulcer

1.7

15.7

290

1734

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

15.7

666

4789

L01BA01

ATC

methotrexate; systemic

1.9

15.7

199

1065

A07AA09

ATC

vancomycin; oral

2.8

15.7

282

WX002

NOMESCO Finland

Sedation and analgesia

1.4

15.7

940

7162

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

15.6

197

1052

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

15.6

754

5545

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

15.6

410

2676

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.9

15.6

239

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

15.6

560

3903

SFA20

NOMESCO Finland

Two-surface restoration

1.2

15.6

3902

35237

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

17.2

15.6

L04AC10

ATC

secukinumab; parenteral

3.9

15.6

116

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

15.6

212

1161

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

15.5

2296

19641

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

15.5

318

1956

D01AC07

ATC

tioconazole; topical

2.0

15.5

166

839

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

15.5

507

3470

A02BA04

ATC

nizatidine; systemic

1.6

15.4

324

2004

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

4.2

15.4

M01AE02

ATC

naproxen; oral, rectal

1.2

15.4

3785

34098

X58

ICD-10 Finland

Exposure to other specified factors

1.4

15.4

875

6611

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.0

15.3

104

Z08

ICPC

Social welfare problem

2.6

15.3

337

K07

ICPC

Swollen ankles/oedema

1.9

15.3

188

997

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

15.2

776

5760

L08

ICPC

Shoulder symptom/complaint

1.3

15.2

1111

8712

D11

ICPC

Diarrhoea

1.4

15.2

840

6318

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

15.2

1258

10036

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

15.1

599

4252

S01AA02

ATC

chlortetracycline; ophthalmic

3.9

15.1

114

G47.3

ICD-10 Finland

Sleep apnoea

1.3

15.1

1098

8601

K59.0

ICD-10 Finland

Constipation

1.7

15.1

300

1830

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

15.1

181

951

S91

ICPC

Psoriasis

3.2

15.1

191

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

15.0

440

2941

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

15.0

2319

19912

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.3

15.0

113

498

SFA30

NOMESCO Finland

Three-surface restoration

1.2

15.0

2382

20514

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

6.3

15.0

S22

ICPC

Nail symptom/complaint

1.6

15.0

352

2240

G04BD08

ATC

solifenacin; oral

1.7

14.9

268

1591

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

14.9

1181

9361

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

14.9

327

2046

R35

ICD-10 Finland

Polyuria

1.7

14.9

300

1837

T74.1

ICD-10 Finland

Physical abuse

2.0

14.9

149

735

-1, ,

NOMESCO Finland

1.2

14.9

2369

20402

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

14.9

413

2730

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

14.8

286

1731

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

14.8

229

1304

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

14.8

762

5664

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

2.8

14.8

252

A97

ICPC

No disease

1.3

14.7

1100

8652

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

14.6

179

947

R01AC07

ATC

nedocromil; nasal

4.1

14.6

F73

ICPC

Eye infection/inflammation other

2.1

14.6

140

680

R13

ICD-10 Finland

Dysphagia

1.6

14.6

327

2058

L29

ICD-10 Finland

Pruritus

2.3

14.5

107

467

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

6.3

14.5

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

6.3

14.5

P18

ICPC

Medication abuse

3.1

14.4

186

SPAT1262

SPAT

Handing over of treatment supplies

1.4

14.4

812

6122

I50.0

ICD-10 Finland

Congestive heart failure

1.7

14.4

267

1600

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

14.4

729

5403

N05AD03

ATC

melperone; systemic

2.9

14.4

234

UKC02

NOMESCO Finland

Cystoscopy

1.4

14.3

663

4839

R5110, ,

SPAT

1.7

14.3

275

1664

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

14.2

261

1559

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.3

14.2

108

478

H10

ICD-10 Finland

Conjunctivitis

1.5

14.2

505

3513

L13.0

ICD-10 Finland

Dermatitis herpetiformis

4.4

14.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

14.2

3787

34275

N06AX26

ATC

vortioxetine; oral

1.5

14.2

494

3423

ZXA00

NOMESCO Finland

Right side

1.3

14.2

1234

9900

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

14.1

211

1190

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

14.1

1068

8412

M01AH02

ATC

rofecoxib; oral

1.5

14.0

517

3621

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

13.9

329

L40

ICD-10 Finland

Psoriasis

2.2

13.9

114

521

H70

ICPC

Otitis externa

2.1

13.9

132

639

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

13.8

306

1919

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

13.8

696

5157

A10BJ02

ATC

liraglutide; parenteral

2.0

13.7

140

697

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

13.7

336

2161

M01AX17

ATC

nimesulide; oral

1.3

13.7

1032

8120

C08CA13

ATC

lercanidipine; oral

1.4

13.6

546

3884

ZXA10

NOMESCO Finland

Bilateral

1.3

13.6

929

7205

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

13.6

123

585

B02.9

ICD-10 Finland

Zoster without complication

1.6

13.5

291

1812

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

3.8

13.5

105

L86

ICPC

Back syndrome with radiating pain

1.6

13.5

304

1915

SPAT1284

SPAT

Extensive health certificate

1.8

13.5

191

1060

P03

ICPC

Feeling depressed

1.4

13.5

789

5983

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.1

13.4

117

548

S94

ICPC

Ingrowing nail

2.2

13.4

105

471

G01AF04

ATC

miconazole; vaginal

1.7

13.4

245

1463

N06AB05

ATC

paroxetine; oral

1.6

13.4

322

2060

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

13.4

326

2093

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

13.3

956

7466

D10AF01

ATC

clindamycin; topical

1.6

13.3

271

1664

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.0

13.3

190

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

13.3

2232

19277

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

13.3

292

1829

M25.5

ICD-10 Finland

Pain in joint

1.2

13.3

1888

16030

L04AC13

ATC

ixekizumab; parenteral

4.7

13.2

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.0

13.2

196

V01AA02

ATC

grass pollen; parenteral

3.4

13.2

135

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.3

13.2

405

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

13.2

279

1731

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

13.2

277

1716

Z01.2

ICD-10 Finland

Dental examination

1.2

13.1

3133

27980

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

13.1

336

2181

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

13.1

681

5066

SPAT1216

SPAT

Assessment of functional ability

1.4

13.1

674

5006

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.1

13.1

122

587

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

13.0

469

3270

P06

ICPC

Sleep disturbance

1.4

13.0

734

5531

H16.9

ICD-10 Finland

Keratitis, unspecified

2.2

13.0

107

490

C84.0

ICD-10 Finland

Mycosis fungoides

10.9

13.0

SDA03

NOMESCO Finland

Periodontal treatment

1.2

13.0

2515

22021

D01

ICPC

Abdominal pain/cramps general

1.3

13.0

803

6140

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

13.0

673

5007

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

12.9

1344

11010

UJH02

NOMESCO Finland

Anoscopy

1.8

12.9

196

1111

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.2

12.9

L16

ICPC

Ankle symptom/complaint

1.4

12.9

708

5316

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

3.4

12.8

128

G04CA02

ATC

tamsulosin; oral

1.3

12.8

837

6449

L56.4

ICD-10 Finland

Polymorphous light eruption

3.8

12.8

100

Z72.1

ICD-10 Finland

Alcohol use

2.5

12.8

313

D07AC04

ATC

fluocinolone acetonide; topical

11.5

12.8

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.8

12.7

177

978

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.8

12.7

182

1015

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

12.7

1614

13530

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

12.6

317

2049

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

12.6

262

1618

30041

ICD-8 Finland

Neuroses, Depressiva

2.9

12.6

196

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

12.6

149

781

Z01.7

ICD-10 Finland

Laboratory examination

1.3

12.6

820

6315

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

12.5

324

2109

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

12.5

1686

14217

-56

ICPC

Dressing/pressure/compress/tamponade

2.3

12.5

378

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.2

12.5

101

460

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

12.4

596

4375

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

12.4

387

2622

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

12.4

336

2209

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

12.4

765

5845

R74

ICPC

Upper respiratory infection acute

1.2

12.4

2426

21240

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

12.4

359

2397

L02

ICPC

Back symptom/complaint

1.4

12.3

630

4674

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

4.8

12.3

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

12.3

1373

11334

H29

ICPC

Ear symptom/complaint other

1.4

12.3

587

4307

WX704

NOMESCO Finland

Intubation

1.5

12.3

416

2868

S07

ICPC

Rash generalized

3.2

12.2

152

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

12.2

277

1748

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

12.2

258

1602

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

5.1

12.2

F60.5

ICD-10 Finland

Anankastic personality disorder

2.3

12.2

370

M10.9

ICD-10 Finland

Gout, unspecified

1.6

12.1

248

1527

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

12.1

422

2925

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

12.1

530

3832

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

12.1

450

3160

N03AX11

ATC

topiramate; oral

1.8

12.1

169

936

R06.2

ICD-10 Finland

Wheezing

1.6

12.1

269

1692

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

12.0

961

7611

V03AB30, ,

ATC

3.7

12.0

100

N05AX12

ATC

aripiprazole; systemic

1.6

12.0

293

1883

N06AB08

ATC

fluvoxamine; oral

2.0

12.0

130

662

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.2

12.0

149

L71.9

ICD-10 Finland

Rosacea, unspecified

1.9

11.9

138

718

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

11.9

417

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

11.9

350

2342

N05AF01

ATC

flupentixol; systemic

2.4

11.9

324

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

11.9

212

1258

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

11.9

773

5948

WQ020, ,

NOMESCO Finland

13.3

11.9

A08

ICPC

Swelling

1.7

11.9

218

1304

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

11.9

246

1519

U05

ICPC

Urination problems other

1.7

11.9

217

1297

P19

ICPC

Drug abuse

2.4

11.9

337

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.7

11.9

231

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

11.8

193

1118

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

11.8

232

1413

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

11.8

182

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

11.8

1039

8334

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

5.4

11.8

C08CA01

ATC

amlodipine; oral

1.2

11.8

1547

12998

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

11.8

548

4004

SPAT1234

SPAT

Support of social functional capacity

1.7

11.8

233

1423

C09CA01

ATC

losartan; oral

1.3

11.7

1040

8346

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

11.7

241

1485

T83

ICPC

Overweight

2.0

11.7

129

660

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

11.7

4669

43453

X15

ICPC

Vaginal symptom/complaint other

1.6

11.7

290

1869

R42

ICD-10 Finland

Dizziness and giddiness

1.3

11.7

1121

9082

N04BC05

ATC

pramipexole; oral

1.5

11.7

325

2151

R52.0

ICD-10 Finland

Acute pain

1.7

11.6

203

1199

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.7

11.6

228

1389

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

11.6

181

1035

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

11.6

111

540

XKD00

NOMESCO Finland

Uroflowmetry

1.4

11.5

577

4268

F01

ICPC

Eye pain

1.8

11.5

180

1031

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.2

11.5

424

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

11.5

390

2691

QDB10, ,

SPAT

2.4

11.4

306

R11

ICD-10 Finland

Nausea and vomiting

1.4

11.4

533

3894

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

11.4

132

687

RS221, ,

NOMESCO Finland

2.2

11.4

425

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.0

11.4

164

SPAT1210

SPAT

Application of cast or individual aid

1.7

11.4

220

1335

RJ411, ,

NOMESCO Finland

3.6

11.4

104

T78.3

ICD-10 Finland

Angioneurotic oedema

2.3

11.4

350

RS340, ,

NOMESCO Finland

4.6

11.4

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

11.4

1446

12103

L13

ICPC

Hip symptom/complaint

1.3

11.3

800

6228

I84

ICD-10 Finland

Hemorrhoids

1.9

11.3

136

717

VALMI, ,

NOMESCO Finland

1.2

11.3

1697

14447

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

11.3

237

1468

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

11.3

123

627

D07BB01

ATC

flumetasone and antiseptics; topical

3.4

11.3

114

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

11.3

713

5463

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

11.3

635

4783

SPAT1202

SPAT

Intra-articular injection

2.0

11.3

124

635

C07AB02

ATC

metoprolol; systemic

1.3

11.3

819

6403

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

11.3

113

560

A99

ICPC

Disease/condition unspecnature/site

1.4

11.2

476

3421

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.8

11.2

204

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

11.2

105

508

L71.0

ICD-10 Finland

Perioral dermatitis

1.9

11.2

126

651

N06AG02

ATC

moclobemide; oral

1.7

11.2

192

1130

P74

ICPC

Anxiety disorder/anxiety state

1.5

11.1

333

2240

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.7

11.1

N05AL01

ATC

sulpiride; systemic

2.4

11.1

305

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

11.0

813

6366

H60

ICD-10 Finland

Otitis externa

1.5

11.0

308

2040

D19

ICPC

Teeth/gum symptom/complaint

1.2

11.0

1814

15581

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

8.0

11.0

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

8.0

11.0

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

11.0

476

3435

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

11.0

416

2931

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

10.9

565

4199

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

10.9

432

3067

A08AB01

ATC

orlistat; oral

3.4

10.9

112

SPAT1252

SPAT

Overall medication plan or its review

1.6

10.9

271

1751

N05BA12

ATC

alprazolam; oral

1.4

10.8

492

3579

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

10.8

193

1147

-31

ICPC

Medical examin/health eval partial

1.5

10.8

374

2589

WQ066, ,

NOMESCO Finland

15.5

10.8

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

10.8

6244

59893

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

3.3

10.7

118

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

10.7

160

904

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

10.7

474

3432

SPAT1267

SPAT

Desensitisation

4.3

10.7

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

4.3

10.7

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.7

10.7

209

RS222, ,

NOMESCO Finland

2.4

10.7

316

M02AA15

ATC

diclofenac; topical

1.5

10.7

316

2120

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

4.4

10.7

M01AC05

ATC

lornoxicam; systemic, rectal

21.4

10.7

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.6

10.7

243

1538

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.2

10.7

373

C09CA06

ATC

candesartan; oral

1.3

10.6

1131

9271

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

10.6

263

1696

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

10.6

2254

19812

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

10.6

205

1245

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

10.6

231

1446

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

10.6

268

1738

D07AC09

ATC

budesonide; topical

7.9

10.5

A01AB10

ATC

natamycin; local oral

1.7

10.5

186

1103

H13

ICPC

Plugged feeling ear

1.3

10.5

875

6963

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

10.5

1180

9735

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.4

10.5

406

2872

M70.2

ICD-10 Finland

Olecranon bursitis

1.9

10.5

135

730

SBA00

NOMESCO Finland

Microbiological examinations

1.9

10.5

134

723

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.0

10.4

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

3.8

10.4

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.7

10.4

192

1152

SPAT1312

SPAT

General health counselling

1.2

10.4

2104

18414

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

10.4

281

1851

NHQ40

NOMESCO Finland

Amputation of toe

2.5

10.3

242

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

10.3

334

2282

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.6

10.3

213

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

10.3

202

1231

SFA00

NOMESCO Finland

Small restoration

1.3

10.3

763

5978

UJD02

NOMESCO Finland

Gastroscopy

1.6

10.3

211

1301

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

10.3

1016

8257

J01CF01

ATC

dicloxacillin; systemic

3.4

10.2

107

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.7

10.2

186

M01AC06

ATC

meloxicam; systemic, rectal

1.2

10.2

1774

15301

SPD01

NOMESCO Finland

Mucosa-supported complete denture

2.9

10.2

159

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.1

10.1

480

WX110, ,

SPAT

1.5

10.1

362

2524

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.4

10.1

275

R05

ICD-10 Finland

Cough

1.2

10.1

1188

9848

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

10.0

115

598

R95

ICPC

Chron obstructive pulmonary disease

2.0

10.0

106

536

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

10.0

279

1848

D01AE16

ATC

amorolfine; topical

1.4

10.0

502

3712

M01AB55

ATC

diclofenac, combinations; oral

1.6

10.0

257

1672

D02BB01

ATC

betacarotene; oral

5.0

10.0

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

5.0

10.0

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.1

10.0

469

F05

ICPC

Visual disturbance other

1.7

10.0

160

924

0540A

ICD-9 Finland

Herpes simplex, Eczema herpeticum

40.0

9.9

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.6

9.9

211

1313

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.9

9.9

161

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

9.9

471

3452

F61

ICD-10 Finland

Mixed and other personality disorders

3.3

9.9

109

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

9.9

168

986

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

9.9

149

845

G04BD11

ATC

fesoterodine; oral

2.0

9.9

106

539

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

2.9

9.9

151

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

9.9

301

2034

205

Kela drug reimbursment

Chronic hypertension

1.3

9.8

984

8005

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

9.8

475

3492

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.6

9.8

197

1209

J04BA02

ATC

dapsone; oral

3.2

9.8

120

H62.0

ICD-10 Finland

Otitis externa in bacterial diseases classified elsewhere

5.1

9.8

L30.4

ICD-10 Finland

Erythema intertrigo

2.3

9.8

310

SPA47

NOMESCO Finland

Precision impression for denture

2.0

9.8

100

500

S08

ICPC

Skin colour change

1.6

9.8

250

1626

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

9.8

605

4623

68408

ICD-8 Finland

Impetigo, Alia definita

8.7

9.7

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

4.7

9.7

-1, ,

ICPC

1.7

9.7

181

1090

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.5

9.7

226

A10BH01

ATC

sitagliptin; oral

1.5

9.7

349

2437

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.6

9.7

226

1440

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.1

9.7

415

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.1

9.7

402

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

9.6

347

2422

E87.6

ICD-10 Finland

Hypokalaemia

1.8

9.6

140

786

RS311, ,

NOMESCO Finland

3.8

9.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

9.6

473

3488

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.5

9.6

239

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.0

9.6

484

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

9.6

275

1836

H16.2

ICD-10 Finland

Keratoconjunctivitis

2.7

9.5

176

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.0

9.5

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

2.9

9.5

154

C03AA03

ATC

hydrochlorothiazide; oral

1.5

9.5

325

2246

WQ021, ,

NOMESCO Finland

8.3

9.5

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

9.5

275

1838

SPE90

NOMESCO Finland

Other partial denture

2.1

9.5

385

A10AE04

ATC

insulin glargine; parenteral

1.4

9.5

417

3018

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

9.5

111

582

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

9.5

196

1213

R06AX25

ATC

mizolastine; oral

3.8

9.5

Z01

ICPC

Poverty/financial problem

3.4

9.4

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

9.4

1209

10116

N05AC02

ATC

thioridazine; oral

1.9

9.3

110

578

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

9.3

462

3411

WZC00, ,

SPAT

1.3

9.3

618

4769

J05AH02

ATC

oseltamivir; oral

2.7

9.3

184

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

9.3

159

936

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.5

9.3

219

M01CB03

ATC

auranofin; oral

3.1

9.3

119

L04AA32

ATC

apremilast; oral

4.5

9.3

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

4.7

9.3

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.0

9.2

135

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

9.2

224

1440

A91

ICPC

Abnormal result investigation NOS

1.6

9.2

229

1480

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

9.2

281

1899

S22.3

ICD-10 Finland

Fracture of rib

1.5

9.2

307

2112

G04BD07

ATC

tolterodine; oral

1.7

9.2

180

1098

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

9.2

162

962

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.2

9.2

319

B07.9

ICD-10 Finland

Verruca simplex

1.6

9.1

220

1412

R52.1

ICD-10 Finland

Chronic intractable pain

2.5

9.1

209

Z2445

NOMESCO Finland

Psychologist

1.5

9.1

290

1976

SPAT1101

SPAT

Orthostatic test

1.7

9.1

151

881

SCA02

NOMESCO Finland

Preventive oral health care

1.3

9.1

811

6505

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.0

9.1

459

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

4.3

9.1

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

4.3

9.1

JN4BD

NOMESCO Finland

Extensive body CT

1.4

9.1

402

2915

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

15.6

9.0

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

36.7

9.0

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

9.0

209

1331

M03BX01

ATC

baclofen; systemic

1.9

9.0

100

516

M71.0

ICD-10 Finland

Abscess of bursa

3.2

9.0

106

SPAT1057

SPAT

Peak expiratory flow measurement

1.9

9.0

116

629

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

2.1

9.0

394

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.4

9.0

235

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

9.0

157

931

R03AK11

ATC

formoterol and fluticasone; inhalant

1.8

9.0

128

716

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.7

8.9

141

812

B82

ICPC

Anaemia other/unspecified

1.8

8.9

120

659

L30

ICD-10 Finland

Other dermatitis

1.8

8.9

137

783

D07XB01

ATC

flumetasone; topical

3.0

8.9

122

N06AX17

ATC

milnacipran; oral

2.4

8.9

242

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

8.9

1534

13200

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.8

8.9

129

725

L84

ICPC

Back syndrome without radiat pain

1.5

8.9

246

1631

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.6

8.8

177

1087

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

8.8

677

5327

RS121, ,

NOMESCO Finland

2.6

8.8

195

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

8.8

271

1835

JN4AD

NOMESCO Finland

Body CT examination

1.4

8.8

376

2710

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.6

8.8

184

N05AF05

ATC

zuclopenthixol; systemic

2.6

8.8

190

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

8.7

1859

16292

L04

ICPC

Chest symptom/complaint

1.4

8.7

322

2259

B86

ICD-10 Finland

Scabies

1.6

8.7

185

1155

B01AA03

ATC

warfarin; systemic

1.3

8.7

685

5413

WX892

NOMESCO Finland

Monitored bed care

1.4

8.6

344

2448

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.0

8.6

461

RD210, ,

NOMESCO Finland

1.8

8.6

125

703

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.8

8.6

125

703

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

8.6

217

1410

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

8.6

290

L90

ICPC

Osteoarthrosis of knee

1.5

8.6

223

1458

A98

ICPC

Health maint/preventive medicine

1.4

8.6

7095

69415

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1.9

8.6

105

560

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

8.6

186

1166

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

8.6

254

1708

E86

ICD-10 Finland

Volume depletion

1.9

8.6

100

525

H10.2

ICD-10 Finland

Other acute conjunctivitis

2.0

8.6

442

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

4.5

8.6

Z00.0

ICD-10 Finland

General medical examination

1.2

8.6

1091

9111

A27

ICPC

Fear of other disease NOS

1.5

8.5

232

1532

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.9

8.5

512

WQ007, ,

NOMESCO Finland

6.9

8.5

H03AA01

ATC

levothyroxine sodium; systemic

1.2

8.5

1185

9985

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.6

8.5

198

1263

M01AE51

ATC

ibuprofen, combinations; systemic

2.3

8.5

285

F02

ICPC

Red eye

1.5

8.5

243

1623

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

8.5

163

992

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

8.4

178

1108

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

8.4

388

2831

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

3.2

8.4

100

S92.5

ICD-10 Finland

Fracture of other toe

1.7

8.4

163

993

R10.0

ICD-10 Finland

Acute abdomen

1.6

8.4

173

1070

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.7

8.4

148

879

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.7

8.4

138

804

A01AC01

ATC

triamcinolone; local oral

2.2

8.4

318

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

8.4

195

1242

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.4

8.4

230

F05.9

ICD-10 Finland

Delirium, unspecified

2.1

8.4

384

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

8.4

111

607

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

3.9

8.4

RS230, ,

NOMESCO Finland

3.0

8.4

116

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.4

849

6914

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

8.4

487

3688

L20

ICPC

Joint symptom/complaint NOS

1.6

8.4

186

1173

H60.1

ICD-10 Finland

Cellulitis of external ear

2.1

8.4

332

F22.0

ICD-10 Finland

Delusional disorder

2.1

8.4

332

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

8.4

232

1539

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

8.3

304

2129

SPAT1285

SPAT

Provision of consultation response

1.5

8.3

268

1832

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

8.3

423

3137

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.9

8.3

523

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.4

8.3

225

L40.4

ICD-10 Finland

Guttate psoriasis

3.1

8.3

106

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

8.3

461

3466

S10

ICPC

Boil/carbuncle

1.5

8.3

292

2032

F32.1

ICD-10 Finland

Moderate depressive episode

1.4

8.3

408

3012

A07EB01

ATC

cromoglicic acid; oral

10.7

8.3

U13

ICPC

Bladder symptom/complaint other

1.7

8.2

136

794

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

8.2

198

1272

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.7

8.2

150

NG1DA

NOMESCO Finland

X-ray of knees

2.1

8.2

374

RF220, ,

NOMESCO Finland

2.2

8.2

302

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.1

8.2

328

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

8.2

142

841

G01AF05

ATC

econazole; vaginal

1.4

8.2

360

2609

A29

ICPC

General symptom/complaint other

1.3

8.2

608

4767

M01AH05

ATC

etoricoxib; oral

1.2

8.2

3538

32707

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

8.2

334

2390

WW200

NOMESCO Finland

Immunization

1.7

8.1

142

842

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.6

8.1

172

1073

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.8

8.1

111

614

N05AN01

ATC

lithium; oral

1.7

8.1

137

806

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

3.6

8.1

R4120

NOMESCO Finland

Occupational therapy

1.4

8.1

334

2394

J01MA06

ATC

norfloxacin; oral

1.3

8.1

587

4588

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.3

8.1

247

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

3.2

8.0

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

3.2

8.0

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

8.0

1453

12544

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.6

8.0

160

983

K08.80

ICD-10 Finland

Toothache NOS

1.3

8.0

510

3913

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

2.5

8.0

187

R4190

NOMESCO Finland

Nutritional therapy

1.5

8.0

247

1676

R05CB03

ATC

carbocisteine; oral

1.9

8.0

103

559

N02BA71

ATC

acetylsalicylic acid, combinations with psycholeptics; systemic

2.0

8.0

426

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

8.0

398

2944

D06BB06

ATC

penciclovir; topical

3.6

8.0

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

8.0

500

3830

Z94.7

ICD-10 Finland

Corneal transplant status

3.8

7.9

Z51.5

ICD-10 Finland

Palliative care

1.5

7.9

259

1778

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

7.9

229

1534

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.5

7.9

235

1583

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

7.9

597

4691

K90.0

ICD-10 Finland

Coeliac disease

1.6

7.9

154

942

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

1.8

7.9

107

591

SPAT1360

SPAT

Extensive global examination

1.4

7.9

317

2263

B02.3

ICD-10 Finland

Zoster ocular disease

3.9

7.8

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

3.6

7.8

N01BB20

ATC

amides - combinations; parenteral

2.1

7.8

315

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

7.8

1283

10978

C08CA02

ATC

felodipine; oral

1.4

7.8

320

2292

G50.1

ICD-10 Finland

Atypical facial pain

1.9

7.8

465

H16.8

ICD-10 Finland

Other keratitis

3.8

7.8

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

2.2

7.8

277

L11

ICPC

Wrist symptom/complaint

1.3

7.7

532

4127

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.3

7.7

233

A12BA01

ATC

potassium chloride; oral

1.7

7.7

146

885

WX213

NOMESCO Finland

Lower leg blockade

2.6

7.7

167

M54

ICD-10 Finland

Dorsalgia

1.3

7.7

713

5745

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.7

1155

9798

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

7.7

200

1309

S01AA03

ATC

neomycin; ophthalmic

2.5

7.7

179

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

1.8

7.7

118

676

H60.8

ICD-10 Finland

Other otitis externa

1.6

7.7

160

995

L29

ICPC

Musculoskeletal sympt/complt other

1.3

7.7

421

3163

N02AJ13

ATC

tramadol and paracetamol; systemic

1.8

7.6

100

546

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

7.6

108

604

H26.02

ICD-10 Finland

Presenil cataract

1.8

7.6

108

604

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

7.6

126

737

L04AC16

ATC

guselkumab; systemic

4.5

7.6

K85

ICPC

Elevated blood pressure

1.3

7.6

599

4732

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

1.9

7.6

462

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

7.6

310

2219

SAA04

NOMESCO Finland

Special examination of mouth

1.4

7.6

328

2371

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.5

7.6

207

1370

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

7.6

296

2102

R78

ICPC

Acute bronchitis/bronchiolitis

1.8

7.6

102

562

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

6.7

7.6

OAB50, ,

SPAT

1.5

7.6

231

1565

K11.70

ICD-10 Finland

Hypoptyalism

3.0

7.5

102

NG1AD

NOMESCO Finland

Knee CT examination

2.1

7.5

313

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.0

7.5

387

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.5

7.5

209

1388

C10AC01

ATC

colestyramine; oral

1.7

7.5

122

710

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.6

7.5

148

907

6840A

ICD-9 Finland

Impetigo[IMPETIGO CONTAGIOSA]

8.8

7.5

R07.0

ICD-10 Finland

Pain in throat

1.3

7.5

455

3468

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.9

7.5

499

Z50.5

ICD-10 Finland

Speech therapy

1.9

7.5

492

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.0

7.5

422

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.2

7.5

281

SPAT1247

SPAT

Outpatient detoxication and monitoring

3.2

7.5

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

3.3

7.5

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.0

7.5

361

EB1SA, ,

SPAT

1.4

7.5

321

2318

X57

ICD-10 Finland

Unspecified privation

1.8

7.5

113

645

F32

ICD-10 Finland

Depressive episode

1.4

7.5

338

2463

K85

ICD-10 Finland

Acute pancreatitis

2.1

7.4

308

S19

ICPC

Skin injury other

1.5

7.4

193

1263

G03CA04

ATC

estriol; systemic, vaginal

1.5

7.4

196

1287

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.6

7.4

163

1026

F60.8

ICD-10 Finland

Other specific personality disorders

2.5

7.4

188

W10

ICD-10 Finland

Fall on and from stairs and steps

1.5

7.4

251

1735

SPAT1281

SPAT

Other administrative function

1.3

7.4

425

3213

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

7.4

583

4604

C84.1

ICD-10 Finland

Sézary disease

80.1

7.4

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.4

501

3879

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

2.7

7.4

136

-59

ICPC

Other therap proced/minor surg NEC

1.7

7.4

122

714

Z09

ICPC

Legal problem

2.8

7.4

125

U01

ICPC

Dysuria/painful urination

1.3

7.4

438

3329

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

13.3

7.4

S01KA02

ATC

hypromellose; ophthalmic

2.1

7.4

336

C10AA05

ATC

atorvastatin; oral

1.2

7.4

1608

14097

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

3.2

7.3

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

7.3

100

553

R06.5

ICD-10 Finland

Mouth breathing

1.3

7.3

446

3402

SPA51

NOMESCO Finland

Determination of bite and dental arch location, demanding

2.6

7.3

154

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

7.3

555

4363

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.4

7.3

284

2016

C10AA01

ATC

simvastatin; oral

1.2

7.3

1504

13123

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.5

7.3

205

1366

05405

ICD-8 Finland

Herpes simplex, Kerato-conjunctivitis herpetica

10.8

7.3

G53.0

ICD-10 Finland

Postzoster neuralgia

3.0

7.3

H92.0

ICD-10 Finland

Otalgia

1.4

7.3

374

2782

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

7.3

546

4287

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

7.3

660

5306

90494, ,

NOMESCO Finland

9.3

7.3

I50

ICD-10 Finland

Heart failure

1.8

7.3

512

D10AX03

ATC

azelaic acid; topical

1.3

7.3

512

3987

S00.0

ICD-10 Finland

Superficial injury of scalp

1.8

7.2

108

614

U02

ICPC

Urinary frequency/urgency

1.3

7.2

726

5904

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

7.2

115

666

Z04

ICD-10 Finland

Examination and observation for other reasons

2.0

7.2

386

P17

ICPC

Tobacco abuse

2.0

7.2

386

M54.3

ICD-10 Finland

Sciatica

1.4

7.2

266

1869

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

7.2

138

840

H04

ICPC

Ear discharge

1.6

7.2

145

894

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.0

7.2

339

EBA10

NOMESCO Finland

Operative extraction of tooth

1.2

7.2

980

8233

A10BX01

ATC

guar gum; oral

1.7

7.2

130

780

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

7.2

352

2600

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

7.1

214

1445

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.7

7.1

133

I45.0

ICD-10 Finland

Right fascicular block

3.1

7.1

NFS99

NOMESCO Finland

Other operation for infection of tendon, joint or bone of hip or thigh

20.0

7.1

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

7.1

174

L63.9

ICD-10 Finland

Alopecia areata, unspecified

2.5

7.1

174

29599

ICD-8 Finland

Schizophrenia, Unspecified type

3.5

7.1

K30

ICD-10 Finland

Functional dyspepsia

1.3

7.1

566

4479

D09

ICPC

Nausea

1.4

7.1

335

2459

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.5

7.1

245

1702

N30.0

ICD-10 Finland

Acute cystitis

1.2

7.1

899

7499

L84

ICD-10 Finland

Corns and callosities

1.6

7.1

148

922

N05AC01

ATC

periciazine; systemic

3.3

7.1

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.5

7.1

199

1327

30180

ICD-8 Finland

Personality disorders, Immatura

3.8

7.0

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

3.8

7.0

S01AA12

ATC

tobramycin; ophthalmic

3.8

7.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.6

7.0

135

823

S70

ICPC

Herpes zoster

1.8

7.0

100

561

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

7.0

457

3520

Z29

ICPC

Social problem NOS

1.7

7.0

132

801

K03.00

ICD-10 Finland

Approximal wear

1.3

7.0

381

2859

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

1.9

7.0

419

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

7.0

1170

10023

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.4

7.0

260

1832

A10BB12

ATC

glimepiride; oral

1.5

7.0

217

1477

SPAT1251

SPAT

Organisation of medication

1.6

7.0

156

988

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

7.0

286

2050

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.7

7.0

113

659

EB1AA, ,

SPAT

1.4

6.9

352

2613

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.1

6.9

317

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.3

6.9

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

6.9

192

1277

L04AB04

ATC

adalimumab; parenteral

1.7

6.9

128

774

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

6.9

615

4935

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.6

6.9

170

1102

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

6.9

109

632

A07EA06

ATC

budesonide; oral, local oral

1.5

6.8

184

1215

M01AB01

ATC

indometacin; systemic, rectal

1.4

6.8

258

1822

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

6.8

297

2151

A10BX07

ATC

[U] liraglutide

2.3

6.8

221

C09AA02

ATC

enalapril; systemic

1.2

6.8

711

5808

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

6.8

292

2110

L91

ICPC

Osteoarthrosis other

2.0

6.8

333

D11AH04

ATC

alitretinoin; oral

6.7

6.8

L41.9

ICD-10 Finland

Parapsoriasis, unspecified

10.9

6.8

WX730

NOMESCO Finland

Conventional respirator

2.0

6.8

347

-54

ICPC

Repair/fix-suture/cast/prosth device

1.8

6.8

531

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.5

6.8

182

1202

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.8

6.7

102

583

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

6.7

287

R55

ICD-10 Finland

Syncope and collapse

1.3

6.7

474

3690

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.4

6.7

268

1911

05403

ICD-8 Finland

Herpes simplex, Cutaneus (Eczema herpeticum)

16.7

6.7

ZX120, ,

SPAT

2.4

6.7

185

S02AA03

ATC

boric acid; otic

2.4

6.7

185

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

6.7

428

3287

K29.2

ICD-10 Finland

Alcoholic gastritis

4.3

6.7

F93.80

ICD-10 Finland

Generalized anxiety in the bardom age

4.3

6.7

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.7

6.7

120

719

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.7

128

780

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.1

6.7

3611

33696

R04

ICPC

Breathing problem other

1.5

6.7

174

1141

M79.1

ICD-10 Finland

Myalgia

1.2

6.7

811

6732

A08AA01

ATC

phentermine; oral

3.5

6.7

B05BB01

ATC

electrolytes; parenteral

3.9

6.7

QXB99, ,

SPAT

1.9

6.7

454

C05AA01

ATC

hydrocortisone; rectal, topical

1.5

6.7

195

1311

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

6.7

223

1540

2920A

ICD-9 Finland

Drug psychoses, Drug withdrawal syndrome

22.5

6.7

QDH01

NOMESCO Finland

Excision of nail bed in toe

3.4

6.7

KGH10

NOMESCO Finland

Operation for phimosis

1.7

6.7

121

728

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.7

6.7

110

645

A10BH05

ATC

linagliptin; oral

1.6

6.7

161

1039

K07.60

ICD-10 Finland

Snapping jaw

1.4

6.7

310

2271

R20.2

ICD-10 Finland

Paraesthesia of skin

1.3

6.6

367

2761

XQ820

NOMESCO Finland

Exposure to medicinal substance

2.8

6.6

110

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.2

6.6

868

7262

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

6.6

428

3294

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.4

6.6

329

2436

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

2.6

6.6

133

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

4.0

6.6

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

1.9

6.6

435

L73.8

ICD-10 Finland

Other specified follicular disorders

2.1

6.6

290

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

2.3

6.6

212

B35.4

ICD-10 Finland

Tinea corporis

2.0

6.6

365

F71

ICPC

Conjunctivitis allergic

3.1

6.6

XKC03

NOMESCO Finland

Water cystometry

1.7

6.5

117

701

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.6

6.5

146

925

A07EC02

ATC

mesalazine; oral, rectal

1.4

6.5

273

1964

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

6.5

512

4043

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.7

6.5

100

574

R1250

NOMESCO Finland

Evaluation of functional capability

1.7

6.5

106

619

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.5

133

825

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

6.5

711

5838

R01AD59

ATC

mometasone, combinations; nasal

1.4

6.5

246

1740

C10AX09

ATC

ezetimibe; oral

1.3

6.5

550

4387

G43.9

ICD-10 Finland

Migraine, unspecified

1.3

6.5

404

3095

SPAT1097

SPAT

Recording of ECG

1.3

6.5

565

4522

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

2.1

6.5

259

R49.01

ICD-10 Finland

Functional dysphonia

1.6

6.4

138

866

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

2.8

6.4

112

M10

ICD-10 Finland

Gout

1.6

6.4

145

921

L63.0

ICD-10 Finland

Alopecia (capitis) totalis

5.3

6.4

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1.7

6.4

109

644

E66

ICD-10 Finland

Obesity

1.4

6.4

281

2038

A03

ICPC

Fever

1.2

6.4

1210

10468

A03BB01

ATC

butylscopolamine; systemic, rectal

3.9

6.4

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

6.4

466

3645

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

3.5

6.4

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

3.5

6.4

R5599

NOMESCO Finland

Other rehabilitation service

1.6

6.4

135

844

160

Kela drug reimbursment

exenatide

1.9

6.4

397

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

1.7

6.4

105

616

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

6.4

397

5113

A02BB01

ATC

misoprostol; oral

3.0

6.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

6.3

125

769

N64.5

ICD-10 Finland

Other signs and symptoms in breast

1.6

6.3

123

754

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

1.7

6.3

104

610

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

2.3

6.3

197

WX402

NOMESCO Finland

General anaesthesia

1.2

6.3

1150

9921

L05

ICPC

Flank/axilla symptom/complaint

1.4

6.3

279

2028

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

6.3

780

6489

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

1.8

6.3

463

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.9

6.3

420

N06AA04

ATC

clomipramine; systemic

1.9

6.3

399

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

2.9

6.3

M54.1

ICD-10 Finland

Radiculopathy

1.5

6.3

174

1158

S09

ICPC

Infected finger/toe

1.6

6.3

153

990

D07BA01

ATC

prednisolone and antiseptics; topical

9.2

6.3

N06AX18

ATC

reboxetine; oral

2.1

6.3

249

N06AX22

ATC

agomelatine; oral

1.6

6.3

140

888

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

3.4

6.3

N02CX04, ,

ATC

1.9

6.3

421

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

6.3

131

818

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

6.3

379

2892

30188

ICD-8 Finland

Personality disorders, Alia definita

3.2

6.2

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.0

6.2

296

R05DA09

ATC

dextromethorphan; oral

2.0

6.2

337

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

1.9

6.2

393

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

3.8

6.2

IEZ99, ,

SPAT

3.8

6.2

A06AC07

ATC

triticum (wheat fibre); oral

3.8

6.2

SPAT1243

SPAT

Psychiatric/psychological examination

1.5

6.2

200

1372

M01AX05

ATC

glucosamine; oral

1.2

6.2

642

5239

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

6.2

385

2947

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.7

6.2

108

643

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.6

6.2

130

812

S99

ICPC

Skin disease other

1.8

6.2

524

SPAT1153

SPAT

Removal of sutures

1.2

6.2

1466

12917

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

6.2

735

6089

-44

ICPC

Preventive immunization/medic

1.3

6.2

352

2662

R81

ICPC

Pneumonia

1.6

6.2

150

970

N05AH02

ATC

clozapine; systemic

1.7

6.2

104

614

N39.3

ICD-10 Finland

Stress incontinence

1.4

6.2

297

2189

GD1AD

NOMESCO Finland

Thorax CT examination

1.4

6.2

212

1474

S20

ICPC

Corn/callosity

1.9

6.1

395

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.7

6.1

555

SPC35

NOMESCO Finland

Production and attachment of fibre-reinforced dental bridge

2.1

6.1

271

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

2.7

6.1

115

L29.2

ICD-10 Finland

Pruritus vulvae

1.8

6.1

533

D06AX07

ATC

gentamicin; topical

5.3

6.1

J01XE01

ATC

nitrofurantoin; oral

1.8

6.1

460

49099

ICD-8 Finland

Bronchitis, unspecified

2.2

6.1

206

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

6.1

101

593

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.8

6.1

453

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

6.1

758

6307

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

2.6

6.1

121

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

1.8

6.1

475

RJ421, ,

NOMESCO Finland

3.3

6.1

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

3.3

6.1

S01AA30

ATC

combinations of different antibiotics; ophthalmic

2.1

6.1

265

OAA80, ,

SPAT

0.7

6.1

321

4234

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

1.9

6.1

340

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

6.1

310

2305

H60.3

ICD-10 Finland

Other infective otitis externa

1.6

6.1

116

708

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

6.1

178

1199

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.0

6.1

279

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

6.1

195

1338

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.5

6.1

139

369

Kela drug reimbursment

Regorafenib

4.1

6.1

3006

Kela drug reimbursment

Baricitinib

3.8

6.1

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

2.1

6.1

246

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

1.7

6.1

105

625

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.6

6.0

119

732

SPAT1235

SPAT

Mental health, emotional support

2.2

6.0

233

F70

ICPC

Conjunctivitis infectious

1.6

6.0

139

888

K04.08

ICD-10 Finland

Other specified pulpit

1.3

6.0

457

3594

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

6.0

631

5156

H57.1

ICD-10 Finland

Ocular pain

1.5

6.0

202

1397

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.6

6.0

121

748

SPAT1139

SPAT

Nutrition survey

1.6

6.0

147

952

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

6.0

307

2284

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.4

6.0

170

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.6

6.0

136

866

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

973

4472

2.35

118.74

1.6

1.3

1487.45

188.89

u/ml

14.47

918

4149

(3001604) Monocytes [#/volume] in Blood

3947

29913

1.67

99.40

7.1

6.2

0.58

0.56

e9/l

7.12

3461

26066

(40760892) CBC W Ordered Manual Differential panel - Blood

3765

28207

1.67

98.99

7.4

6.7

—

(3006315) Basophils [#/volume] in Blood

3950

29963

1.67

98.94

7.1

6.2

0.04

e9/l

2.72

3465

26075

(3013115) Eosinophils [#/volume] in Blood

4056

31044

1.66

97.53

7.4

6.5

0.24

0.19

e9/l

25.17

3622

27425

(3019198) Lymphocytes [#/volume] in Blood

4045

31094

1.65

94.27

7.1

6.2

2.00

e9/l

0.09

3632

27764

(3007853) Bacteria identified in Skin by Aerobe culture

1241

6843

1.97

92.99

2.0

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4360

34267

1.64

92.02

10.5

9.0

4.15

4.00

e9/l

3.46

3850

29923

(3022096) Basophils/100 leukocytes in Blood

3534

27244

1.56

74.04

7.2

6.4

0.66

0.67

0.62

3334

25528

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

137

247

5.62

72.14

1.3

1.2

10.33

10.83

u/ml

0.04

114

183

(3006504) Eosinophils/100 leukocytes in Blood

3609

28195

1.53

69.54

7.2

6.3

3.38

2.84

26.46

3418

26502

(3019069) Monocytes/100 leukocytes in Blood

3625

28363

1.53

69.24

7.4

6.6

8.44

8.29

2.18

3443

26716

(3024561) Albumin [Mass/volume] in Serum or Plasma

2962

22201

1.55

68.78

5.6

5.0

35.71

36.28

g/l

6.19

2774

20701

(3010726) Horse dander IgE Ab [Units/volume] in Serum

420

1691

2.57

67.25

1.2

1.1

5.47

2.14

u/ml

5.22

321

923

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

458

1968

2.41

63.73

1.2

1.1

3.43

2.76

u/ml

0.56

322

1060

(3002030) Lymphocytes/100 leukocytes in Blood

3714

29551

1.50

63.28

7.3

6.3

28.47

29.60

8.49

3532

27925

(3018010) Neutrophils/100 leukocytes in Blood

3666

29114

1.50

62.88

7.1

6.1

56.41

55.96

1.45

3494

27490

(3018418) pH of Serum or Plasma

2083

14703

1.57

61.59

4.0

3.9

7.40

0.05

391

2838

(3023368) Bacteria identified in Blood by Culture

1909

13224

1.59

61.12

5.0

4.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

116

210

5.59

60.84

1.3

1.1

13.17

3.63

u/ml

0.69

110

193

(3012494) Peanut IgE Ab [Units/volume] in Serum

148

331

4.53

60.79

1.2

13.03

13.83

u/ml

0.03

115

225

(3003888) Timothy IgE Ab [Units/volume] in Serum

415

1762

2.43

59.23

1.2

1.1

7.73

6.12

u/ml

1.08

305

1008

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

150

6.32

56.11

1.1

4.90

4.40

u/ml

0.10

124

(3011841) English Walnut IgE Ab [Units/volume] in Serum

145

6.26

53.23

1.1

9.54

7.23

u/ml

0.17

117

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

7.88

52.59

1.9

1.5

16.49

4.84

u/ml

0.74

(3008401) Mugwort IgE Ab [Units/volume] in Serum

389

1692

2.37

52.53

1.2

1.1

3.04

1.15

u/ml

2.54

274

809

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

105

7.29

51.90

1.0

0.44

0.04

u/ml

2.49

(3021589) Normoblasts [#/volume] in Blood

3345

26767

1.45

51.14

11.1

9.0

0.00

e9/l

0.09

2737

21812

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

921

5546

1.75

49.72

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

909

5492

1.74

48.42

1.9

1.7

—

(40758558) Short blood count panel - Blood

2027

14839

1.50

48.39

7.9

7.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

7.49

46.90

1.1

2.67

2.34

u/ml

0.07

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1955

14281

1.50

46.90

2.6

2.2

2.73

2.82

mg/l

0.92

1721

12258

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

115

6.57

46.55

1.1

0.70

1.69

u/ml

0.46

(3014133) Dog dander IgE Ab [Units/volume] in Serum

326

1383

2.41

46.52

1.1

13.51

4.35

u/ml

5.22

246

694

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

117

6.45

45.79

1.1

1.16

3.94

u/ml

0.40

(3013707) Erythrocyte sedimentation rate by Westergren method

4928

42781

1.44

45.63

4.4

3.8

11.50

10.29

mm/h

8.24

4640

39906

(3020874) Milk IgE Ab [Units/volume] in Serum

192

629

3.10

45.26

1.5

1.1

12.51

1.39

u/ml

1.85

136

269

(36304419) Bacteria [Presence] in Urine

2033

15107

1.47

44.29

3.3

3.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3376

27560

1.40

43.61

6.9

5.9

11.70

11.77

umol/l

0.07

3180

25957

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1223

8191

1.59

43.25

4.6

4.2

0.81

0.82

mmol/l

3.92

1157

7724

(3014599) Egg white IgE Ab [Units/volume] in Serum

187

624

3.04

42.72

1.5

1.1

14.07

2.89

u/ml

1.36

135

219

(3030467) Casts [#/volume] in Urine by Automated count

2035

15226

1.46

42.44

3.4

3.1

0.43

0.35

e6/l

0.82

1563

11402

(3042936) Bacteria identified in Isolate by Culture

1122

7420

1.60

41.74

2.2

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2576

20187

1.42

41.51

2.1

1.9

92.82

96.85

pmol/l

4.63

1457

10794

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4840

42220

1.41

41.14

8.7

7.0

81.63

78.16

u/l

3.66

4606

39833

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

101

6.57

41.06

1.0

1.1

0.57

0.40

u/ml

0.20

(3031040) Bacteria [#/volume] in Urine by Automated count

4529

39103

1.39

40.64

5.0

4.1

3056.77

1264.20

e6/l

0.73

488

(4200892) Spirometry reversibility

628

3625

1.80

38.78

1.5

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

1586

11477

1.48

38.67

2.8

2.6

7.09

6.66

e6/l

0.26

1406

10242

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

8.20

37.08

1.0

1.1

34.44

17.83

u/ml

0.94

(3018095) Leukocytes [#/volume] in Urine

2539

20154

1.39

36.79

3.9

3.6

88.97

84.53

e6/l

0.10

1781

13631

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2871

23278

1.37

36.43

6.7

6.5

1.21

mmol/l

3.42

2687

21384

(3015377) Calcium [Moles/volume] in Serum or Plasma

2228

17327

1.40

36.36

3.5

3.1

2.35

mmol/l

1.75

1999

15502

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3520

29493

1.36

36.16

3.3

2.9

99.37

93.33

ug/l

0.55

3311

27732

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

621

3650

1.76

35.97

1.8

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

286

1283

2.27

35.90

1.1

12.55

6.18

u/ml

3.19

201

565

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1184

8179

1.53

35.85

2.0

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2076

15984

1.41

35.79

1.4

1.3

2.18

1.82

u/ml

0.44

562

4291

(3002582) Erythrocytes [#/volume] in Urine

2147

16634

1.40

35.67

3.4

3.1

52.93

90.24

e6/l

0.98

1651

12579

(3021960) Folate [Moles/volume] in Serum or Plasma

1529

11147

1.46

35.48

1.6

1.5

20.20

20.31

nmol/l

0.11

1370

9739

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3119

25705

1.36

35.36

7.0

6.9

1.21

1.22

mmol/l

3.21

2657

22020

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2909

23734

1.36

35.09

2.5

2.3

74.66

74.10

nmol/l

0.50

2706

21872

(40768443) Skin Pathology biopsy report

427

2263

1.94

34.44

1.2

—

(3000494) Fungus identified in Specimen by Culture

965

6446

1.57

33.85

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

160

559

2.90

33.75

1.2

1.1

1.86

1.33

u/ml

0.21

122

184

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1225

8638

1.50

33.40

3.6

2.8

2.44

2.43

mmol/l

1.23

1035

7548

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

7.03

32.51

1.0

7.27

0.15

u/ml

1.61

(3022948) Iron [Moles/volume] in Serum or Plasma

1193

8427

1.49

32.14

2.5

13.05

13.77

umol/l

2.32

1113

7892

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

107

5.64

32.07

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5273

47486

1.36

31.46

4.4

4.0

14.46

14.54

pmol/l

1.53

4892

43721

(3015736) pH of Urine

2898

23984

1.34

30.48

3.6

3.1

6.01

5.95

0.41

251

2281

(3026008) Bacteria identified in Urine by Culture

2108

16643

1.37

30.18

3.2

2.7

—

(3002385) Erythrocyte distribution width [Ratio]

5879

54016

1.40

29.99

19.4

14.4

14.98

14.70

0.15

5784

53035

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1089

7679

1.49

29.36

2.5

2.41

g/l

0.15

1000

7131

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1015

7093

1.50

28.55

2.6

21.88

23.26

2.09

853

6157

(3044889) 12 lead EKG panel

4202

36846

1.31

28.55

3.7

3.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6501

60991

1.47

28.02

16.7

11.9

22.31

21.74

mg/l

0.69

5254

47062

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2389

19407

1.34

27.86

3.8

3.3

32.41

32.90

u/l

0.16

2259

18481

(3026782) Osmolality of Urine

1444

10862

1.41

27.30

2.9

2.8

533.69

548.99

mosm/kgh2o

1.66

1224

9325

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5991

55459

1.39

27.26

5.2

4.6

1.80

2.00

mu/l

2.17

5626

51801

(3037467) Urinalysis macro (dipstick) panel - Urine

4603

41010

1.31

27.12

4.8

4.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

239

1123

2.16

26.82

1.1

1.98

0.37

u/ml

2.84

139

334

(3016502) Oxygen saturation in Arterial blood

698

4561

1.58

26.63

7.5

8.2

95.21

95.89

1.51

668

4381

(3019309) Folate [Moles/volume] in Red Blood Cells

1169

8507

1.44

26.54

1.9

1.7

1248.02

1168.95

nmol/l

2.13

912

6513

(3003396) Base excess in Arterial blood by calculation

769

5142

1.55

26.51

7.3

7.7

1.32

0.91

mmol/l

1.75

602

3974

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1868

14731

1.35

26.25

2.3

2.2

203.87

219.91

u/l

0.32

1771

13921

(3007164) IgA [Mass/volume] in Serum or Plasma

1784

13971

1.36

26.22

1.5

2.36

2.17

g/l

4.14

1095

8675

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

768

5149

1.54

26.14

7.2

7.7

5.17

5.07

kpa

1.74

733

4905

(3022217) INR in Platelet poor plasma by Coagulation assay

2650

22004

1.31

26.01

13.8

12.0

1.17

1.19

inr

0.66

862

6778

(3027801) Oxygen [Partial pressure] in Arterial blood

767

5149

1.54

25.94

7.1

7.6

12.22

12.93

kpa

2.75

731

4904

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

739

4921

1.55

25.93

2.8

2.6

0.22

g/l

0.29

689

4613

(3035350) Ketones [Presence] in Urine by Test strip

3420

29401

1.30

25.81

4.0

3.4

0.00

estimate

0.13

722

5969

(3026493) Urate [Moles/volume] in Serum or Plasma

1690

13165

1.36

25.60

2.8

2.5

1977.61

3855.82

umol/l

2.11

1480

11782

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

157

4.23

25.23

1.5

9.19

8.45

ug/l

0.67

157

(3013826) Glucose [Moles/volume] in Serum or Plasma

3717

32382

1.29

24.99

5.4

4.7

6.47

mmol/l

0.04

3448

29728

(3002173) Hemoglobin [Mass/volume] in Arterial blood

647

4216

1.58

24.93

7.7

8.3

121.57

122.73

g/l

0.70

625

4094

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2092

16903

1.33

24.65

3.0

2.5

55.66

62.77

u/l

0.74

1947

15643

(3003458) Phosphate [Moles/volume] in Serum or Plasma

977

6975

1.46

24.40

5.9

6.8

1.08

1.09

mmol/l

0.30

928

6537

(3019150) Specific gravity of Urine by Refractometry

1648

12871

1.36

24.37

4.3

3.6

1.02

kg/l

0.16

227

1945

(3021601) Nitrite [Presence] in Urine by Test strip

3403

29386

1.29

24.22

5.2

4.6

0.00

estimate

1.34

715

5785

(3016031) Almond IgE Ab [Units/volume] in Serum

5.42

24.19

1.1

1.78

1.05

u/ml

0.55

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1231

9184

1.40

24.09

2.9

2.7

1.07

1.13

e6/l

0.17

716

5088

(3019060) Gas panel - Arterial blood

471

2864

1.68

23.94

4.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

762

5196

1.52

23.89

2.9

2.4

34.93

46.25

u/l

0.61

650

4451

(3033658) Prothrombin time (PT) actual/Normal

1772

14030

1.34

23.86

4.6

4.3

91.97

92.17

0.13

1719

13662

(3009261) Glucose [Presence] in Urine by Test strip

3421

29642

1.28

23.39

4.0

3.4

0.00

estimate

1.95

702

5639

(3036312) Salmon IgE Ab [Units/volume] in Serum

6.08

23.19

1.2

1.1

5.61

1.37

u/ml

1.28

(3011397) Hemoglobin [Presence] in Urine by Test strip

1723

13645

1.34

23.04

3.9

3.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

116

422

2.77

22.83

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

125

473

2.67

22.80

1.4

1.3

8.64

2.40

u/ml

3.39

254

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

284

3.19

22.77

1.6

1.4

29.06

20.12

u/ml

0.46

(3027945) Reticulocytes/100 erythrocytes in Blood

790

5499

1.49

22.35

2.7

3.1

1.68

1.71

0.29

701

4904

(3009508) Creatinine [Moles/volume] in Urine

1946

15752

1.31

22.17

3.3

7.67

7.93

mmol/l

1.41

1697

13714

(3014576) Chloride [Moles/volume] in Serum or Plasma

835

5902

1.46

21.83

7.6

7.3

104.22

104.66

mmol/l

1.76

835

5897

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1140

8594

1.38

20.69

2.1

1.7

1.50

1.39

5.56

1000

7707

(3037522) Nuclear Ab [Titer] in Serum

1128

8503

1.38

20.46

1.4

419.59

563.36

titre

2.37

196

1704

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

5.01

20.35

1.0

1.1

17.19

8.48

u/ml

0.93

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

893

6473

1.43

20.33

2.9

3.2

7.53

7.33

umol/l

0.09

748

5527

(3008152) Bicarbonate [Moles/volume] in Arterial blood

445

2782

1.63

20.30

7.7

6.8

24.87

24.33

mmol/l

1.90

421

2634

(3029937) Albumin [Presence] in Urine by Test strip

1915

15639

1.30

20.07

4.7

3.7

0.00

estimate

0.12

698

5617

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

728

5120

1.46

19.44

4.0

3.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1209

9337

1.35

18.65

3.8

3.4

531.96

569.94

ng/l

0.06

850

6260

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.84

18.63

1.0

1.1

0.03

0.04

u/ml

0.17

(3048689) Calprotectin [Mass/mass] in Stool

1150

8860

1.35

17.97

2.6

2.5

137.89

119.36

ug/g

0.76

937

7051

(3036481) Cortisol [Moles/volume] in Serum or Plasma

797

5795

1.42

17.72

2.6

2.2

345.87

372.64

nmol/l

3.61

739

5333

(3019420) Tryptase [Mass/volume] in Serum or Plasma

370

2.64

17.51

1.4

5.80

6.95

ug/l

0.80

329

(3000991) Gas panel - Venous blood

660

4653

1.46

17.35

8.3

9.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1036

7900

1.36

17.26

2.2

2.7

29.75

29.81

0.12

1001

7674

(3000492) Spirometry study

820

6044

1.40

16.82

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1587

12913

1.29

16.61

1.9

2.0

1.19

1.08

mg/l

0.43

1185

9546

(3014111) Lactate [Moles/volume] in Serum or Plasma

622

4381

1.46

16.42

7.2

7.8

1.38

1.36

mmol/l

0.16

606

4274

(36660697) Celiac disease serology panel - Serum

788

5828

1.39

15.80

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

521

3577

1.49

15.66

2.8

3.2

170.56

179.22

ng/l

0.19

465

3196

(3012516) Albumin [Mass/volume] in Urine

1566

12823

1.28

15.43

3.5

3.3

634.25

367.34

mg/l

1.03

1038

8375

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1284

10256

1.30

15.35

1.3

27.35

26.56

iu/ml

0.07

359

3191

(3017181) Myelocytes/100 leukocytes in Blood

640

4589

1.43

15.32

4.2

4.3

0.91

0.82

0.28

188

1462

(3023103) Potassium [Moles/volume] in Serum or Plasma

6239

59304

1.29

15.26

18.0

13.1

3.93

3.94

mmol/l

2.79

6080

57506

(46235355) HIV 1 and 2 tests - Meaningful Use set

2144

18233

1.24

15.22

2.1

2.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

281

2.75

15.20

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1328

10667

1.30

15.20

1.8

1.6

73666225.23

30690122.22

pmol/l

1.15

1143

9091

(3019550) Sodium [Moles/volume] in Serum or Plasma

6221

59129

1.29

15.10

17.9

13.0

139.33

139.60

mmol/l

15.29

6066

57489

(3020779) Urea [Moles/volume] in Serum or Plasma

634

4554

1.43

15.03

7.6

8.7

8.65

8.42

mmol/l

0.36

608

4372

(3021440) Promyelocytes/100 leukocytes in Blood

612

4383

1.43

14.74

4.3

4.4

0.11

0.10

0.12

161

1258

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

103

3.99

14.70

1.1

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1103

8684

1.31

14.60

3.0

2.8

3.57

3.07

e6/l

0.51

594

4597

(3023183) Ammonium ion [Moles/volume] in Plasma

208

1163

1.81

14.30

2.5

3.0

33.76

35.43

umol/l

0.45

194

1071

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1953

16535

1.24

14.26

1.8

1.7

—

(3020891) Body temperature

294

1815

1.64

14.15

5.7

4.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1616

13412

1.26

14.05

3.9

12.15

11.00

mg/mmol

0.24

1029

8748

(3002179) Metamyelocytes/100 leukocytes in Blood

588

4217

1.43

14.05

3.9

4.1

0.54

0.62

0.48

159

1278

(3025159) Blasts/100 leukocytes in Blood

585

4192

1.43

14.04

4.2

4.4

0.65

0.23

0.33

137

1064

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

412

6000

0.67

14.01

4.0

3.8

32.68

32.25

0.33

308

4352

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1413

11555

1.27

13.90

3.0

3.1

1155.64

1286.42

ng/l

0.64

1199

9639

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5318

49800

1.23

13.81

5.5

4.7

38.57

38.42

mmol/mol

0.57

5027

46710

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2603

22781

1.22

13.67

4.2

3.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4494

41432

1.21

13.53

3.6

3.0

46.07

40.20

u/l

5.27

4238

39253

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1205

9694

1.29

13.48

1.3

4.33

9.56

u/ml

5.84

451

3972

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2110

18100

1.23

13.47

3.6

3.2

28.21

88.46

ng/l

1.18

1225

10257

(40761535) Cells panel - Urine sediment

572

4113

1.42

13.46

3.9

3.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

733

5497

1.37

13.43

3.9

4.5

243.28

243.32

u/l

0.00

700

5212

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

509

3585

1.45

13.42

2.4

2.3

5.78

6.72

ug/l

0.91

449

3116

(3028707) Methadone [Presence] in Urine by Screen method

303

1911

1.61

13.39

2.8

2.9

—

(3023520) Reticulocytes [#/volume] in Blood

550

3933

1.43

13.35

2.4

2.9

71.01

70.14

e9/l

0.18

385

2883

(3020961) Endomysium IgA Ab [Titer] in Serum

519

3682

1.44

13.16

1.2

199.06

212.86

titre

0.05

110

(40761511) CBC panel - Blood by Automated count

6644

63930

1.32

13.12

14.7

11.0

—

(3012501) Base excess in Blood by calculation

205

1175

1.76

13.00

3.9

4.3

2.43

2.35

mmol/l

0.17

150

745

(3017143) Hepatitis C virus Ab [Presence] in Serum

1174

9454

1.28

12.99

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

226

1334

1.71

12.92

1.7

—

(3018001) Oat IgE Ab [Units/volume] in Serum

4.83

12.79

1.1

1.0

4.08

0.12

u/ml

0.82

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

450

3130

1.46

12.67

1.7

1.5

—

(3044941) Cell count panel - Synovial fluid

142

731

1.96

12.66

1.5

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

141

727

1.95

12.51

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

164

893

1.85

12.34

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6597

63516

1.30

12.20

11.8

9.1

27.04

26.27

u/l

1.82

6416

61494

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.48

12.07

1.7

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

285

1818

1.59

12.04

1.2

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

403

2771

1.48

12.04

1.8

2.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

283

1803

1.59

12.02

1.2

1.1

—

(3003338) MCHC [Mass/volume]

5784

54884

1.23

11.97

21.0

14.9

332.81

333.08

g/l

1.43

5741

54414

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

366

2478

1.50

11.81

9.1

10.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

285

1831

1.58

11.69

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

253

1582

1.62

11.63

5.4

3.8

1.34

1.39

mmol/l

0.29

245

1554

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

206

1224

1.70

11.54

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

206

1225

1.70

11.51

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

239

1480

1.63

11.43

1.9

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

295

1924

1.55

11.34

1.6

1.8

0.24

0.23

g/l

1.16

278

1838

(3047181) Lactate [Moles/volume] in Blood

245

1530

1.62

11.33

4.8

5.9

1.36

1.27

mmol/l

0.72

214

1332

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

135

3.19

11.16

1.2

1.1

—

(3010421) pH of Blood

223

1367

1.65

11.11

3.7

4.2

7.42

0.23

211

1247

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

264

1689

1.58

11.05

2.0

2.59

2.20

ug/l

0.15

233

1503

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

507

3698

1.40

11.00

4.0

4.4

78.57

80.76

ng/l

0.20

461

3280

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

300

1986

1.53

10.79

1.6

1.8

1.22

1.16

g/l

3.07

284

1898

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

202

1217

1.68

10.77

3.6

3.8

57.23

56.52

0.38

202

1217

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1718

14716

1.21

10.70

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1598

13593

1.22

10.67

1.7

1.6

1.46

1.38

mmol/l

2.81

1380

11732

(3021879) Hepatitis B virus core Ab [Presence] in Serum

763

5959

1.31

10.56

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

235

2.56

10.44

1.1

1.2

0.31

0.29

g/l

1.01

189

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

142

784

1.82

10.30

1.6

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

213

1317

1.63

10.29

1.8

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

532

3966

1.37

10.10

7.9

9.9

24.64

24.59

mmol/l

0.11

527

3945

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

277

2.39

9.94

1.0

21.71

14.50

u/ml

1.14

164

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

360

2.20

9.84

1.5

1.6

—

(3039000) Anion gap in Blood

172

1019

1.70

9.81

5.1

7.2

11.14

11.33

mmol/l

0.30

154

902

(3011288) Drugs identified in Urine by Screen method

424

3060

1.41

9.80

3.0

2.9

—

(3018572) Chloride [Moles/volume] in Blood

172

1020

1.70

9.77

5.1

7.2

104.18

105.36

mmol/l

2.49

154

903

(3002032) Base excess in Venous blood by calculation

659

5101

1.32

9.72

5.0

5.3

1.80

1.69

mmol/l

0.31

549

4204

(3015171) Extractable nuclear Ab [Units/volume] in Serum

348

2427

1.45

9.72

1.3

0.28

1.21

u/ml

2.98

193

(3021447) Carbon dioxide [Partial pressure] in Venous blood

662

5128

1.32

9.71

5.0

5.3

5.91

5.82

kpa

1.36

633

4974

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

221

1406

1.59

9.53

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

116

619

1.88

9.41

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

532

4012

1.35

9.38

3.0

2.5

69.81

72.31

ml/min/173m2

0.71

200

1523

(3020630) Protein [Mass/volume] in Serum or Plasma

480

3568

1.37

9.29

2.1

2.6

67.15

66.69

g/l

0.67

434

3292

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

907

1.72

9.27

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

224

1444

1.57

9.14

1.8

2.3

10.90

10.29

g/l

1.28

194

1310

(3021788) Differential panel - Synovial fluid

146

844

1.74

9.12

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

160

950

1.70

9.08

1.7

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

118

641

1.85

9.07

5.2

7.2

11.61

11.04

mg/l

0.52

111

597

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

151

886

1.72

8.96

1.7

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

133

754

1.77

8.90

1.5

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

218

2.48

8.88

1.1

1.2

111.65

109.40

0.27

194

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

434

3201

1.38

8.83

5.6

6.0

24.21

23.86

mmol/l

1.55

415

3160

(40761536) Microorganisms panel - Urine sediment

674

5303

1.30

8.81

4.6

3.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1475

1.55

8.75

1.8

2.3

2.96

2.94

g/l

0.09

197

1350

(1001926) Buprenorphine [Presence] in Urine by Screen method

466

3487

1.36

8.66

2.4

2.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

484

3644

1.35

8.64

1.7

1.9

1.24

1.31

g/l

0.38

464

3369

(3000475) Leukocytes [#/volume] in Synovial fluid

174

1071

1.64

8.63

1.7

14457.06

12576.91

e6/l

0.22

117

776

(3052851) Hemolysis interference index of Serum or Plasma

247

1650

1.51

8.59

2.8

2.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

605

4712

1.31

8.53

2.7

10.73

10.27

g/l

1.79

566

4340

(40768797) Stomach Pathology biopsy report

884

7218

1.25

8.52

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

272

2.29

8.51

1.4

1.3

137.42

133.04

nmol/l

0.27

272

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

524

4006

1.33

8.44

3.8

3.7

1.22

1.23

mmol/l

2.09

453

3482

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

192

1220

1.59

8.37

1.7

2.2

38.28

38.21

g/l

0.06

163

1093

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1560

1.51

8.24

1.8

2.2

3.95

3.63

g/l

2.54

205

1436

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

337

2411

1.41

8.23

9.3

10.1

24.32

24.20

mmol/l

0.25

327

2344

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1562

1.51

8.19

1.8

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3046

27856

1.15

8.18

2.7

2.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

176

1107

1.60

8.03

1.7

2.2

0.01

0.00

g/l

0.50

154

1028

(3019225) pH of Specimen

354

4797

0.72

7.99

4.3

3.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

233

1563

1.50

7.98

1.8

2.2

7.40

7.32

g/l

0.28

204

1437

(3023419) Bacteria identified in Sputum by Culture

111

619

1.80

7.90

3.1

—

(40767503) Oxygen content in Capillary blood by calculation

172

1082

1.60

7.85

2.6

2.5

16.67

16.71

0.04

552

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

174

1099

1.59

7.81

1.7

2.2

0.00

g/l

-0.00

154

1027

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

102

557

1.84

7.78

2.4

2.5

—

(3022145) Colonoscopy Study observation

727

5874

1.26

7.67

1.3

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

203

1335

1.53

7.64

1.9

2.3

0.56

0.87

g/l

0.85

167

1183

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

184

1185

1.56

7.61

1.4

—

(3016879) Cocaine [Presence] in Urine

532

4138

1.31

7.59

2.3

2.2

—

(44813793) Dust mix specific IgE antibody measurement

540

1.84

7.59

1.0

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

185

1195

1.56

7.56

1.7

2.2

0.00

0.02

g/l

1.70

163

1111

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

115

660

1.75

7.45

1.7

1.8

—

(3007461) Platelets [#/volume] in Blood

7036

68873

1.31

7.45

24.0

17.5

264.76

258.31

e9/l

13.37

6887

67155

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

380

2826

1.36

7.39

1.7

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5668

54369

1.17

7.35

4.4

3.8

5.80

5.74

mmol/l

2.42

5294

50336

(3021387) Prolactin [Units/volume] in Serum or Plasma

465

3570

1.32

7.30

1.6

323.30

317.98

mu/l

0.10

399

3207

(3009542) Hematocrit [Volume Fraction] of Blood

7028

68808

1.30

7.23

24.2

17.6

40.19

40.44

1.19

6614

65277

(3035941) MCH [Entitic mass]

7039

68933

1.30

7.21

23.8

17.4

30.04

0.02

6962

68070

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5114

48713

1.15

7.19

3.8

3.6

—

(3024731) MCV [Entitic volume]

7038

68929

1.30

7.14

23.9

17.4

90.10

89.98

1.35

6960

68067

(3010813) Leukocytes [#/volume] in Blood

7040

68954

1.30

7.12

24.0

17.5

7.10

6.75

e9/l

3.29

6880

67064

(3026361) Erythrocytes [#/volume] in Blood

7039

68943

1.30

7.12

24.0

17.5

4.50

4.53

e12/l

5.09

6874

67088

(3000963) Hemoglobin [Mass/volume] in Blood

7041

68966

1.30

7.11

24.1

17.6

134.44

135.44

g/l

7.80

6964

68099

(3025941) Bacteria identified in Stool by Culture

486

3777

1.30

6.99

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

331

2435

1.37

6.91

1.6

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

428

1.90

6.89

1.8

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

168

1089

1.55

6.80

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

293

2.09

6.78

2.7

3.0

122.78

172.97

umol/l

0.93

163

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

680

1.70

6.74

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

148

934

1.59

6.73

5.4

5.3

355.71

374.19

umol/l

0.86

127

819

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.07

6.70

1.1

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

126

765

1.66

6.69

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

303

2212

1.38

6.64

1.3

1.6

4.89

11.81

u/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

286

2068

1.40

6.64

3.1

3.8

3.52

3.42

g/l

0.54

266

1963

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

542

1.78

6.63

1.8

2.2

32.48

32.28

0.16

535

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

236

1654

1.44

6.54

2.2

2.4

341.00

482.44

ug/l

0.77

215

1517

(3025296) Carrot IgE Ab [Units/volume] in Serum

10.00

6.52

1.0

0.49

5.94

u/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

529

6591

0.79

6.51

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

238

1675

1.43

6.45

1.2

1.3

81.72

134.10

titre

0.74

156

(3000764) Benzodiazepines [Presence] in Urine

560

4486

1.27

6.37

2.3

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

344

2583

1.35

6.33

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

216

1500

1.45

6.30

1.4

299.37

299.68

ug/g

0.01

129

811

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

212

1468

1.45

6.28

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

126

780

1.62

6.23

1.4

1.8

59.40

65.99

mmol/l

0.86

104

630

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1437

12638

1.17

6.22

1.5

—

(3027944) Amphetamines [Presence] in Urine

554

4447

1.26

6.20

2.2

2.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

172

1146

1.51

6.18

2.2

2.3

132.83

130.95

g/l

0.45

133

868

(3028300) Cannabinoids [Presence] in Urine

562

4521

1.26

6.17

2.3

2.1

—

(3011985) Renin [Units/volume] in Plasma

116

705

1.65

6.17

1.3

1.6

51.99

63.45

mu/l

0.31

106

633

(3024354) Oxygen [Partial pressure] in Venous blood

543

4357

1.26

6.10

4.7

5.0

4.81

4.80

kpa

0.03

512

4222

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

327

1.96

6.06

1.8

1.6

95736.00

1949637.92

iu/ml

—

(3027008) Opiates [Presence] in Urine

559

4515

1.26

5.94

2.3

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

129

814

1.59

5.92

1.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

151

991

1.53

5.84

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

151

991

1.53

5.84

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

264

1927

1.38

5.84

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

721

5999

1.22

5.82

9.1

5.9

—

(1616796) Gas panel - Central venous blood

173

1170

1.49

5.81

3.4

3.7

—

(3007542) Rye IgE Ab [Units/volume] in Serum

3.78

5.79

1.2

1.0

74.35

0.11

u/ml

0.48

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

244

2.09

5.79

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

206

2.19

5.71

1.3

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

181

1241

1.47

5.68

5.4

6.4

200.75

717.92

iu/ml

2.26

169

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

246

2.08

5.67

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

100

599

1.68

5.66

2.4

75.22

71.77

1.92

577

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5581

53799

1.14

5.56

14.6

10.5

90.64

89.29

ml/min/173m2

4.06

4603

43649

(3052592) Norovirus Ag [Presence] in Stool

2.93

5.54

1.1

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

196

1374

1.44

5.49

2.5

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

331

2529

1.32

5.46

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

206

1462

1.42

5.40

2.8

5.3

0.34

u/ml

0.03

118

839

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

173

2.26

5.35

3.7

4.8

—

(3011412) CD3 cells [#/volume] in Blood

113

710

1.60

5.32

2.7

1.36

1.32

e9/l

0.13

601

(44816559) Phosphatidylethanol [Mass/volume] in Blood

195

1375

1.43

5.31

1.5

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

246

2.04

5.30

1.2

1.3

156.61

162.08

mmol/24h

0.17

246

(3020191) Ethanol [Moles/volume] in Serum or Plasma

536

1.68

5.24

1.5

1.55

1.28

promille

0.87

410

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

107

668

1.61

5.19

1.3

1.4

365.41

353.43

pmol/l

0.10

582

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

585

1.65

5.13

1.9

2.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

236

1731

1.37

5.12

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

476

3844

1.25

5.10

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

624

5193

1.22

5.04

1.2

117.46

149.92

iu/ml

1.36

216

1941

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

787

6700

1.19

5.00

2.1

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

971

8416

1.17

5.00

2.2

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

514

4209

1.24

4.87

1.4

22.76

23.55

iu/l

0.23

432

3527

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

480

1.69

4.83

1.1

1.3

32.00

161.43

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

480

1.69

4.83

1.1

1.3

183.64

184.85

titre

0.00

(4062490) Immunoglobulin typing, IgG

106

674

1.58

4.79

1.4

—

(3008295) Osmolality of Serum or Plasma

581

1.62

4.78

1.5

1.6

278.13

283.30

mosm/kgh2o

1.26

452

(3027135) IgG subclass 1 [Mass/volume] in Serum

106

675

1.58

4.77

1.4

6.44

6.61

g/l

0.26

489

(3024139) IgG subclass 3 [Mass/volume] in Serum

106

675

1.58

4.77

1.4

0.34

0.39

g/l

1.25

488

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

266

2012

1.33

4.75

1.1

8.35

5.22

u/ml

0.30

279

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

207

1506

1.38

4.75

4.3

3.4

175.35

2881.54

u/ml

0.84

181

1276

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

114

739

1.55

4.74

1.6

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

114

739

1.55

4.74

1.6

1.7

—

(1761868) Lipid panel - Serum or Plasma

2034

22083

0.89

4.74

2.5

2.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

106

676

1.57

4.74

1.4

2.82

2.81

g/l

0.04

492

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

275

2093

1.32

4.71

1.6

1.8

1.50

1.44

g/l

0.60

244

1797

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

584

4870

1.21

4.64

2.6

2.4

6829.21

6463.23

u/l

0.09

220

1952

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

873

7553

1.17

4.60

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

526

1.64

4.57

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

428

1.71

4.55

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

428

1.71

4.55

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

428

1.71

4.55

1.7

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

240

1810

1.33

4.40

4.6

5.3

0.92

0.91

0.20

219

1686

(3042631) Mycobacterium sp identified in Specimen

515

1.62

4.20

2.4

2.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.84

4.20

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

132

908

1.46

4.19

1.5

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1819

16650

1.12

4.16

3.5

2.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

558

1.58

4.09

1.1

5.50

7.75

iu/ml

0.49

131

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

265

2050

1.30

4.09

1.6

0.16

11.65

iu/ml

0.74

408

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

442

1.66

4.08

1.6

1.5

33.48

35.64

0.17

273

(3019977) pH of Arterial blood

250

1.88

4.08

3.8

2.8

7.42

7.43

0.32

(3034274) Bile acid [Moles/volume] in Serum --fasting

210

1574

1.34

4.05

2.3

2.6

5.84

6.83

umol/l

0.58

162

1178

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1371

12359

1.13

4.04

2.4

2.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

973

1.43

4.04

3.3

4.6

88400.67

1209.29

u/ml

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

238

1821

1.31

3.99

4.6

5.3

1.91

1.69

1.68

216

1691

(3024928) Oxygen saturation in Venous blood

151

1078

1.41

3.94

5.0

5.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

261

1.84

3.91

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

375

4575

0.81

3.89

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

283

1.80

3.89

1.6

1.5

—

(3000012) Reticulocyte production index

581

1.55

3.89

2.0

2.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

100

2.40

3.87

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

158

1142

1.39

3.85

2.2

3.3

1.33

1.99

ratio

—

102

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

258

2007

1.29

3.84

2.8

3.4

168.45

174.18

0.53

247

1914

(3051611) Lipemic interference index of Serum or Plasma

545

1.56

3.79

2.8

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

489

4098

1.20

3.74

3.0

3.3

4.54

4.56

pmol/l

0.19

433

3681

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

362

1.69

3.71

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

149

1074

1.39

3.70

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

161

1177

1.37

3.68

2.3

3.4

35.43

59.29

mg/l

1.10

128

956

(3034860) Kappa light chains.free [Mass/volume] in Serum

161

1177

1.37

3.68

2.3

3.4

71.12

103.57

mg/l

0.24

128

954

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1492

13605

1.12

3.60

2.5

2.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

190

1.95

3.60

2.4

2.6

69.64

84.31

ug/l

0.48

182

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

298

1.75

3.59

1.1

1.2

92.37

98.12

u/l

0.13

258

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

234

1815

1.30

3.58

1.5

1.6

608.57

359.49

titre

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

269

1.79

3.57

1.1

1.2

120.84

105.76

1.71

242

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

506

1.56

3.57

1.2

80.53

72.12

u/l

0.17

461

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

428

1.62

3.56

1.5

1.3

1.72

1.42

nmol/l

1.25

387

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

234

1.84

3.52

2.0

1.9

148.83

119.68

ug/min

0.15

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

250

1.80

3.46

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

250

1.80

3.46

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

295

1.73

3.43

2.2

3.0

72.68

95.69

umol/l

0.42

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

166

1.99

3.41

2.6

2.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

100

2.30

3.41

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

127

906

1.41

3.39

1.4

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

466

1.57

3.36

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

564

1.51

3.30

2.7

2.8

549.85

538.39

e6/l

0.08

447

(3024263) Appearance of Synovial fluid

247

1.78

3.29

1.3

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

337

1.66

3.28

2.4

2.7

257.78

311.31

e6/l

0.51

198

(3019832) Treponema pallidum Ab [Presence] in Serum

1285

11682

1.12

3.26

1.8

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

372

3082

1.22

3.25

1.3

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

504

0.49

3.23

2.6

2.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

348

2867

1.22

3.21

4.2

4.3

129.56

129.94

g/l

0.11

339

2797

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

287

1.71

3.18

1.1

1.2

25.05

20.30

u/l

0.37

246

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

310

1.68

3.16

1.6

5.41

5.70

u/l

0.07

260

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

115

818

1.41

3.14

4.7

3.5

73.54

631.54

u/ml

1.10

108

757

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

555

1.50

3.13

2.7

2.8

0.22

0.21

e9/l

0.05

447

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

378

3151

1.21

3.11

1.5

1.6

—

(3036180) Methadone [Presence] in Urine

502

1.52

3.04

2.3

3.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

480

4102

1.18

3.01

2.3

2.1

12.04

11.53

nmol/l

0.57

424

3696

(3004451) EKG impression Narrative

196

1.84

2.99

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

347

1.62

2.96

2.4

2.6

43.06

43.24

0.02

188

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

110

787

1.40

2.94

2.7

3.0

21.71

20.61

nmol/l

0.38

103

756

(3004716) Salmonella sp identified in Stool by Organism specific culture

474

4058

1.18

2.91

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

257

1.71

2.91

1.1

1.2

99.58

89.89

0.90

116

(3021901) Oxygen saturation in Capillary blood

127

933

1.37

2.90

3.0

3.4

—

(3013512) EKG study

1245

13546

0.90

2.85

3.4

3.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

447

1.52

2.81

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

569

1.46

2.81

1.6

58.23

53.91

0.42

359

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

154

1172

1.32

2.79

1.8

1.9

177.08

190.05

pmol/l

0.87

138

1112

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

5.99

2.69

1.0

33.07

9.98

u/ml

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

333

1.59

2.68

1.7

1.6

—

(3002619) Bacteria identified in Specimen by Culture

132

1.97

2.68

1.2

1.1

—

(3036489) Thrombin time

296

2450

1.21

2.67

2.3

3.1

21.51

21.57

0.04

264

2114

(3009871) Measles virus Ab [Titer] in Serum

219

1.74

2.66

1.9

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

280

2307

1.22

2.65

1.6

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

188

1482

1.27

2.64

1.4

1.6

102.54

109.70

u/ml

0.59

259

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

382

1.55

2.63

1.1

1483.34

1485.09

miu/ml

0.00

382

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

154

1185

1.30

2.61

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

266

1.66

2.60

1.1

94.00

92.12

0.24

118

(3015235) Bicarbonate [Moles/volume] in Capillary blood

171

1336

1.28

2.58

3.5

4.2

25.13

24.40

mmol/l

1.55

166

1306

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

104

756

1.38

2.57

1.3

1.2

0.10

0.37

nmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

180

1417

1.27

2.56

1.4

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

324

2719

1.20

2.54

1.5

9.33

9.10

u/l

0.14

257

2165

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

143

1095

1.31

2.52

1.5

1.7

—

(3037756) Immunofixation for Serum or Plasma

106

777

1.37

2.50

1.5

1.6

—

(3037121) Protein [Mass/volume] in Urine

239

1951

1.23

2.49

4.2

3.7

0.29

0.36

g/l

0.42

147

941

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

325

0.46

2.46

1.4

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

489

4260

1.16

2.45

5.5

3.9

33.08

28.67

ug/l

0.12

397

3324

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

178

1411

1.27

2.42

1.3

1.4

5.80

11.53

iu/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

348

2957

1.18

2.40

1.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

234

1.67

2.39

1.5

2.30

4.23

—

(3049717) Cytology report of Urine Cyto stain

179

1423

1.26

2.38

1.9

2.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

392

1.51

2.38

1.6

2.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

182

1.76

2.37

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

137

1053

1.30

2.37

1.5

1.6

0.78

0.73

g/l

0.25

106

817

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

683

1.38

2.36

1.3

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

229

1.66

2.31

1.3

1.4

74.12

117.21

nmol/24h

0.83

229

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

267

2228

1.20

2.27

2.5

4.0

92.13

93.05

0.28

256

2148

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.75

2.26

2.1

1.7

34.45

46.03

umol/l

1.05

(3041354) Potassium [Moles/volume] in Venous blood

520

0.59

2.26

2.3

3.92

4.05

mmol/l

1.13

513

(40760888) Immunoglobulin light chains.free panel - Serum

117

887

1.32

2.25

2.2

3.5

—

(3035285) Chloride [Moles/volume] in Venous blood

518

0.60

2.23

2.3

105.71

105.34

mmol/l

0.17

511

(3051651) Icteric interference index of Serum or Plasma

366

1.50

2.22

3.2

3.6

—

(3008898) HLA-B27 [Presence]

320

2727

1.18

2.16

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1129

0.73

2.16

3.2

3.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.29

2.13

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.62

2.13

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

411

1.46

2.12

4.0

4.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

412

1.46

2.10

1.4

161572.84

63865.71

e6/l

0.37

286

(3030313) Adrenal Ab [Titer] in Serum

2.00

2.09

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

124

1.85

2.05

1.5

2.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.50

2.05

1.0

3.2

—

(3044640) Blood type and Crossmatch panel - Blood

1929

18234

1.08

2.05

2.5

2.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

153

1219

1.26

2.04

1.2

1.3

2.61

3.37

u/ml

0.23

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

540

1.39

2.04

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

103

1.94

2.04

1.3

1.6

6.85

439542.16

nmol/l

1.08

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

193

1580

1.23

2.02

1.4

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

618

1.36

2.01

3.3

5.9

6.92

7.00

mmol/l

0.09

517

(1002224) Polysomnography panel

304

2600

1.17

1.99

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5794

56845

1.08

1.98

4.6

4.0

2.72

2.81

mmol/l

13.50

5458

53384

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

202

1666

1.22

1.98

1.4

251.60

243.25

u/ml

0.14

120

1014

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

193

1.66

1.98

2.5

2.3

14.51

16.11

umol/l

0.46

193

(3016038) Potassium [Moles/volume] in Urine

344

1.48

1.97

1.2

1.7

29.91

34.71

mmol/l

0.85

314

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

291

2484

1.18

1.96

2.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.54

1.94

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

177

1446

1.23

1.91

1.8

2.0

10.54

10.65

mg/l

0.06

167

1353

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

249

2103

1.19

1.91

1.4

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

483

0.62

1.90

1.9

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

556

1.37

1.90

2.0

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

122

956

1.28

1.89

2.7

3.4

—

(3014891) Appearance of Pleural fluid

0.00

1.88

0.0

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

292

1.51

1.85

1.3

180.89

320.95

u/l

1.60

270

(3039162) Centromere protein B Ab [Units/volume] in Serum

100

767

1.31

1.83

1.3

36.93

50.45

u/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

787

0.71

1.83

1.4

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

221

1.58

1.83

1.6

1.5

13.94

14.33

pmol/l

0.20

183

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

318

1.48

1.81

2.3

2.9

208.77

102.78

nmol/l

0.41

313

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.04

1.79

1.0

0.13

0.08

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

168

1376

1.22

1.79

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

256

2182

1.18

1.78

3.2

3.6

24.97

25.14

mmol/l

0.34

248

2106

(3010838) Calcium [Moles/time] in 24 hour Urine

113

885

1.28

1.78

1.8

2.0

5.13

5.17

mmol/24h

0.04

104

789

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

132

1054

1.25

1.78

2.4

160.48

100.18

ug/min

0.39

662

(40768441) Liver Pathology biopsy report

436

1.40

1.77

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

168

1379

1.22

1.76

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

109

1.83

1.76

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

272

1.51

1.74

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

224

1.56

1.74

2.5

2.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.33

1.74

1.2

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

139

1.73

1.74

1.4

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

142

1147

1.24

1.73

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

467

4165

1.13

1.73

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

325

2830

1.15

1.73

1.8

2.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

447

1.39

1.72

2.9

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

257

1.52

1.71

2.0

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

257

1.52

1.71

2.0

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

148

1.69

1.4

2.3

883.17

780.90

e6/l

0.15

111

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

104

813

1.28

1.68

1.1

1.55

1.48

g/l

1.04

735

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

236

2010

1.18

1.68

3.9

4.2

51.71

49.87

0.54

231

1984

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

207

1747

1.19

1.64

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

112

1.78

1.63

1.8

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

246

2109

1.17

1.62

6.6

7.5

8.83

9.07

kpa

1.29

238

2053

(3042111) Morphology [Interpretation] in Bone marrow Narrative

721

1.29

1.61

1.6

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

294

2557

1.15

1.61

1.4

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

197

1.57

1.61

2.8

2.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

278

1.48

1.59

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

200

1690

1.19

1.58

1.3

24.32

36.59

u/ml

0.42

109

(3028433) Virus identified in Specimen by Culture

206

1.55

1.58

1.0

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

3.00

1.57

1.2

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

106

1.79

1.57

1.1

1.5

14.51

12.98

g/l

0.28

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

296

1.45

1.56

1.8

1.6

5.28

4.90

nmol/l

0.05

229

(3024666) Lithium [Moles/volume] in Serum or Plasma

499

1.34

1.55

12.5

11.0

0.59

mmol/l

0.03

457

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.42

1.53

1.3

1.5

256.19

495.99

nmol/l

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

145

1.65

1.52

1.5

1.4

233.98

125.08

nmol/l

0.41

106

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

136

1112

1.23

1.52

1.1

3.10

3.39

u/ml

0.12

540

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

1.52

0.0

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

159

1323

1.20

1.50

1.3

36.10

40.07

u/ml

0.11

125

(4034850) Laboratory test

205

1746

1.18

1.49

11.4

8.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.86

1.49

1.1

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

116

1.72

1.47

1.4

1.2

337.00

261.59

pmol/l

0.55

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

111

892

1.25

1.47

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

995

9294

1.08

1.46

4.0

3.9

20.48

21.80

1.83

396

4117

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

653

1.29

1.46

1.3

1.2

—

33.67

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

276

1.45

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.50

1.45

6.1

4.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

132

1.67

1.44

1.5

2.0

16217.46

18577.09

e6/l

0.05

(3022689) Creatine [Moles/volume] in Urine

152

0.46

1.42

1.3

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

311

1.41

30.2

28.6

97.62

126.47

ug/l

2.91

266

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

177

0.51

1.39

1.9

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1462

13877

1.06

1.36

2.4

2.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

119

1.68

1.36

1.2

1.4

36.83

34.21

0.09

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.61

1.36

1.0

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

502

1.32

1.36

1.1

1.2

—

59.02

—

(3016135) IgD [Mass/volume] in Serum

2.94

1.35

1.0

1.2

27.32

66.79

mg/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

220

1902

1.16

1.35

2.0

1.9

—

(3044007) Cell count panel - Peritoneal fluid

127

1.65

1.35

1.5

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

310

2746

1.13

1.35

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

369

3306

1.12

1.33

1.9

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

146

1222

1.20

1.33

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

488

1.31

1.3

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

200

1.50

1.31

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

692

1.26

1.29

1.4

7.82

7.70

mmol/l

0.11

681

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.08

1.27

1.3

1.2

—

(3013466) aPTT in Blood by Coagulation assay

2.08

1.27

1.1

34.23

36.85

—

(3000330) Specific gravity of Urine by Test strip

221

2525

0.87

1.26

2.6

3.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.72

1.26

1.4

1.2

0.87

139.75

mg/l

1.20

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

146

1.57

1.25

5.7

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

146

1.57

1.25

5.7

2.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1234

11690

1.06

1.23

4.3

4.4

1.94

3.02

ug/l

2.15

1085

10512

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

493

1.30

1.23

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

493

1.30

1.23

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

179

1.51

1.22

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

130

1087

1.20

1.22

1.6

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

494

1.30

1.22

1.1

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5706

56231

1.05

1.20

4.2

3.7

4.58

4.69

mmol/l

14.78

5394

53116

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

673

1.25

1.19

1.8

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

262

2318

1.13

1.19

1.8

1.9

42.66

38.78

u/l

2.54

236

2114

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

497

1.29

1.17

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

497

1.29

1.17

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

181

1.49

1.17

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

498

1.29

1.16

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

179

1546

1.16

1.3

5.90

11.33

u/ml

1.13

245

(3027456) Digoxin [Moles/volume] in Serum or Plasma

649

1.25

1.16

2.9

3.1

0.79

0.83

nmol/l

0.33

490

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

605

1.26

1.15

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.80

1.14

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

274

1.39

1.14

10.5

6.1

208.71

11012.09

u/ml

0.49

(3017569) Oxygen content in Arterial blood

199

1.46

1.13

2.0

2.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

283

1.38

1.13

1.4

1.6

3.31

3.37

u/field

0.01

211

(3044009) aPTT.lupus sensitive (LA screen)

1.84

1.12

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

191

1.47

1.12

1.5

1.8

0.11

0.22

nmol/l

1.71

136

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

716

1.23

1.11

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.70

1.10

1.5

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

600

1.25

1.10

1.8

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

176

1526

1.16

1.10

1.3

8.29

5.85

u/ml

0.26

156

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

459

4212

1.09

2.4

2.3

15.06

21.23

au/ml

0.75

369

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.38

1.09

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

106

882

1.20

1.08

1.2

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.19

1.08

1.3

1.5

15.34

25.12

pmol/l

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

416

1.30

1.07

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.12

1.05

5.0

3.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1018

9643

1.06

1.04

1.6

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.71

1.04

2.1

2.0

6.34

7.62

mmol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

471

1.27

1.04

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

277

2486

1.12

1.03

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

254

1.38

1.03

3.5

7.1

76.52

70.66

mg/l

0.26

201

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

375

1.31

1.03

1.5

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

446

1.28

1.02

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

131

1118

1.17

1.02

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.69

1.00

4.0

8.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

171

1492

1.15

1.00

1.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

351

1.31

0.99

1.9

1.5

5.53

6.41

u/l

0.62

304

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

225

0.62

0.99

1.9

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

226

2010

1.13

0.99

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

310

3408

0.90

0.99

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.61

0.99

1.4

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

413

1.28

0.98

1.1

—

(3042517) Benzodiazepines panel - Urine

115

1.56

0.98

1.2

2.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

129

1104

1.17

0.98

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.17

0.98

1.2

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.17

0.98

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

476

1.26

0.97

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

335

1.31

0.97

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

176

1995

0.88

0.96

2.1

1.8

—

(40757373) Influenza virus identified in Isolate

100

1.60

0.96

1.7

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

461

1.26

0.93

2.6

2.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.77

0.93

13.0

11.7

5.47

5.99

mmol/l

0.28

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.61

0.93

1.7

2.26

1.56

mg/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.61

0.93

1.1

0.84

0.68

umol/24h

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

101

1.58

0.92

3.3

2.9

10.56

24.67

mg/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

312

3414

0.91

0.92

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

310

3392

0.91

0.92

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

131

1130

1.16

0.92

3.2

2.1

1.05

0.78

nmol/l

1.82

112

963

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

312

3411

0.91

1.4

—

(3017732) Neutrophils [#/volume] in Blood

446

4131

1.08

0.89

2.4

2.5

6.79

4.70

e9/l

1.24

389

3488

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5651

55810

1.04

0.89

4.0

3.7

1.42

1.47

mmol/l

12.60

5328

52522

(3028717) Thiamine [Mass/volume] in Blood

1.74

0.89

1.1

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.69

0.88

1.1

1.2

50.14

57.56

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.69

0.88

6.9

4.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

594

0.79

0.87

3.1

2.1

15.08

23.69

mg/l

0.80

149

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

411

3799

1.08

0.87

5.8

5.9

1.67

1.35

mmol/l

0.98

295

2767

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

359

1.28

0.87

2.8

2.9

28.89

27.21

umol/l

0.54

349

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.86

0.87

1.5

1.0

—

(3009343) pH of Capillary blood

421

3902

1.08

0.84

5.8

5.9

7.41

0.11

397

(3047189) Immunofixation for 24 hour Urine

191

0.63

0.84

1.6

1.7

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.78

0.84

1.0

—

3.40

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

586

1.21

0.84

1.9

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

335

1.28

0.83

3.6

8.03

8.42

mg/l

0.17

265

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

274

1.31

0.82

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

222

1.35

0.82

1.9

3.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

387

4167

0.92

0.82

1.6

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

139

1217

1.14

0.82

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

424

3939

1.08

0.81

5.8

5.9

5.22

5.10

kpa

2.30

401

3771

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

554

1.21

0.79

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.62

0.77

3.6

2.6

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.55

0.77

1.7

4.89

4.18

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.55

0.77

1.7

2.09

1.92

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.55

0.77

1.7

1.91

1.37

mg/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.58

0.77

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

417

3881

1.08

0.77

1.3

46.84

48.83

au/ml

0.05

188

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

119

1037

1.15

0.76

1.3

6.11

4.36

u/ml

0.59

464

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

140

1.43

0.76

1.2

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

164

1461

1.12

0.76

1.5

1.7

3.59

3.61

mmol/l

0.11

151

1375

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.54

0.74

2.4

2.5

185.07

170.04

ug/g

0.22

(21494755) Public health laboratory ask at order entry panel

743

7791

0.95

0.74

1.3

—

(3020491) Glucose [Moles/volume] in Blood

477

1.22

0.73

1.6

1.8

6.38

6.25

mmol/l

0.16

355

(3048879) Bone marrow aspiration report

109

0.55

0.72

1.8

2.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

127

1119

1.14

0.71

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.62

0.71

1.3

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.75

0.71

1.4

1.5

78.99

73.87

—

(3036670) Protein [Mass/volume] in Synovial fluid

117

1.45

0.71

1.2

38.34

38.70

g/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.92

0.70

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

309

0.74

0.70

1.1

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

343

3681

0.93

0.70

1.5

—

(3045142) Bone marrow Pathology biopsy report

535

1.20

0.70

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

453

1.21

0.70

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

628

1.18

0.69

1.8

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

118

1.44

0.68

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

546

1.19

0.68

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

583

1.18

0.67

1.6

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

117

0.60

0.67

1.0

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

266

1.28

0.67

3.6

2.2

10.56

9.73

mg/l

0.38

224

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.55

0.67

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

237

0.72

0.66

1.2

1.0

862.17

741.88

ng/l

0.54

157

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

147

1635

0.90

0.66

1.3

3.91

4.13

ug/l

0.11

138

1521

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.59

0.65

1.0

4.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

166

0.66

0.64

1.0

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

727

1.16

0.63

1.1

91.23

95.19

0.63

683

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5438

53803

1.03

0.63

3.7

3.4

1.32

1.25

mmol/l

9.21

5097

50382

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.66

0.61

3.4

2.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

201

2187

0.92

0.60

2.2

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

280

1.25

0.60

1.7

2.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

280

1.25

0.60

1.7

2.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

144

1297

1.11

0.59

1.2

1.1

14.60

10.58

au/ml

—

(3044290) Cell count panel - Cerebral spinal fluid

151

1365

1.11

0.58

1.7

1.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

160

1458

1.10

0.54

1.7

1.8

21.69

23.85

e6/l

0.08

130

1118

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

179

1640

1.09

0.54

1.6

1.7

495.08

469.22

mg/l

0.23

171

1559

(3005570) Glucose [Moles/volume] in Urine

551

1.16

0.54

2.3

2.0

—

0.82

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

160

1459

1.10

0.54

1.7

1.9

890.35

3520.22

e6/l

0.52

133

1175

(3015183) Erythrocyte sedimentation rate

393

0.81

0.53

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

480

0.83

0.53

1.2

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

200

1845

1.08

0.52

7.3

8.1

1.47

1.30

mg/l

2.02

191

1750

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

192

0.73

0.52

1.4

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

313

1.21

0.52

2.7

3.0

150.30

151.10

au/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

0.62

0.52

2.3

1.6

0.47

0.37

ug/l

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

214

1.26

0.51

2.6

1.7

17.00

155.88

au/ml

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

124

1120

1.11

0.51

2.3

1.8

2.60

3.53

titre

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

100

1.40

0.51

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

1.28

0.50

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

956

0.89

0.50

2.4

2.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

175

1609

1.09

0.50

1.9

2.0

4.41

4.30

iu/l

0.04

633

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

233

1.24

0.50

1.1

1.2

—

(21494434) Karyotype in Bone marrow

416

1.18

0.50

1.2

—

(3045414) Leukocytes [Presence] in Urine

276

2586

1.07

0.49

1.7

1.8

—

(3019174) dRVVT (LA screen)

1.49

0.49

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

501

1.16

0.48

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

560

0.85

0.48

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

190

1.26

0.47

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

255

0.78

0.47

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

243

0.78

0.46

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

422

4418

0.95

0.46

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.43

0.46

1.6

1.3

23.29

663.05

u/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

200

1.25

0.45

1.4

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.60

0.45

1.0

1.3

—

8.38

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

111

1006

1.10

0.45

1.1

117.06

114.80

0.27

916

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

228

1.23

0.44

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

192

1.25

0.44

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.37

0.43

1.8

4.9

—

(3001556) Androgen free Index in Serum or Plasma

129

0.70

0.43

1.2

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.61

0.43

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

649

1.12

0.42

3.8

4.4

92.33

80.32

u/ml

0.10

196

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.43

0.41

3.8

6.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.41

0.0

4.1

—

138.67

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.51

0.41

1.0

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

326

0.83

0.41

2.5

2.6

56.14

51.87

umol/l

0.34

291

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

887

0.90

0.40

1.2

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.47

0.40

1.0

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

114

1.31

0.40

2.1

2.7

1.26

1.15

umol/l

0.74

107

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.33

0.40

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

577

1.13

0.39

1.3

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.36

0.39

2.6

2.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

159

1.26

0.39

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

729

1.11

0.39

2.3

—

(3035933) Granulocytes/100 leukocytes in Blood

315

1.17

0.39

1.4

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

262

2762

0.95

0.39

7.3

6.5

24.41

24.40

mmol/l

0.03

246

2640

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.41

0.39

3.9

6.1

—

(4146454) Self-monitoring of blood glucose

441

0.86

0.38

2.4

2.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1040

0.91

0.38

1.6

1.4

6.70

6.85

mmol/l

0.26

951

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.36

0.38

1.3

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

151

1.26

0.38

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

136

0.73

0.38

1.5

1.4

—

(4035726) Immunohistochemistry procedure

444

4259

1.04

0.37

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

651

0.89

0.37

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

401

1.15

0.37

1.1

0.98

1.06

u/l

0.82

178

(3003694) ABO and Rh group [Type] in Blood

2014

19786

1.02

0.37

1.7

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

467

1.13

0.37

1.5

11.85

11.42

umol/l

0.15

444

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

117

1078

1.08

0.36

1.3

3.16

3.94

u/ml

0.21

383

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

125

1.28

0.36

1.1

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

694

6724

1.03

0.35

2.7

2.8

0.63

0.74

ug/l

3.22

432

4183

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.65

0.35

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.62

0.35

7.4

5.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

178

0.78

0.34

2.4

2.3

2.04

1.74

mmol/l

—

135

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.37

0.34

1.4

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

335

3205

1.05

0.33

1.3

209.21

228.02

miu/ml

0.44

153

1548

(3051387) C reactive protein [Mass/volume] in Capillary blood

111

1196

0.93

0.33

4.1

3.2

27.41

25.74

mg/l

0.16

714

(3004809) Band form neutrophils/100 leukocytes in Blood

805

1.09

0.33

3.4

1.31

1.40

0.11

718

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

360

0.86

0.33

1.1

1.2

13.67

15.59

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

130

1210

1.07

0.33

1.7

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

191

1.20

0.33

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

228

1.18

0.32

4.4

4.6

—

(3044927) Protein electrophoresis panel - Urine

378

1.14

0.32

1.4

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

192

1.20

0.31

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

110

1.27

0.31

1.6

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

137

1281

1.07

0.31

1.4

1.3

21.09

21.17

u/l

0.01

122

1080

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.34

0.31

1.6

1.3

0.36

1.63

mmol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

115

1069

1.08

0.31

1.1

—

(3007463) Buprenorphine [Presence] in Urine

1.32

0.30

3.3

4.6

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.32

0.30

5.6

7.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

694

1.09

0.30

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

230

1.17

0.30

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.29

0.29

1.6

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

231

1.17

0.29

4.0

2.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

429

1.12

0.29

1.4

1.3

—

(3022313) Gas panel - Capillary blood

288

2995

0.96

0.28

6.7

6.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

152

1432

1.06

0.28

1.4

1.5

72.50

124.56

pmol/l

2.48

146

1399

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

139

1.22

0.28

1.4

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

407

0.88

0.28

1.2

1.4

12905.33

72954.60

e6/l

2.24

245

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.29

0.28

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

708

1.09

0.28

1.2

1.3

34.82

37.85

u/l

0.11

611

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

103

1.26

0.27

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

1.25

0.27

1.0

1.3

—

115.99

—

(3024471) HLA-A [Type]

242

1.16

0.27

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

119

0.75

0.27

1.0

—

(40758292) HTLV I+II Ab panel - Serum

120

0.75

0.27

1.2

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

140

1.21

0.27

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

677

6596

1.03

0.27

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.19

0.26

4.6

8.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

104

1.25

0.26

1.6

2.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

104

1.25

0.26

1.1

—

(3004775) Volume in Urine collected for unspecified duration

341

0.88

0.26

2.4

2.2

603.33

618.02

0.06

236

(3034426) Prothrombin time (PT)

234

1.15

0.26

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

309

0.87

0.25

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

162

1702

0.95

0.25

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

224

0.85

0.25

3.7

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

224

0.85

0.25

7.5

5.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

141

1486

0.95

0.25

1.5

0.34

0.45

nmol/l

1.52

112

1195

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

568

1.09

0.25

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

455

0.90

0.25

1.3

1.4

1914.93

2314.44

e6/l

0.25

327

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.20

0.25

1.8

1.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

244

0.86

0.24

1.0

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

453

0.90

0.23

1.1

1.18

1.05

ratio

0.59

171

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

919

1.07

0.23

2.1

1.6

2080.00

1951.43

titre

—

(3004959) Base excess in Arterial cord blood by calculation

304

1.12

0.22

1.0

-3.23

-1.06

mmol/l

—

(3006598) pH of Arterial cord blood

304

1.12

0.22

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

200

1.15

0.22

2.6

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

200

1.15

0.22

2.6

1.9

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

400

1.10

0.21

1.1

1.2

3.29

15.12

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

130

1234

1.05

0.21

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.6

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3002256) Pathology report gross observation

718

7030

1.02

0.21

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

387

0.90

0.21

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

2.28

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

392

1.10

0.20

1.7

2.1

1.14

1.98

u/field

1.20

175

(40768806) Pleura Pathology biopsy report

386

0.90

0.20

1.4

1.6

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

1.17

0.20

5.4

7.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.20

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

250

0.88

0.20

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

747

0.93

0.20

2.1

2.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.22

0.20

1.0

1.1

1.42

1.62

umol/24h

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

605

1.07

0.20

2.4

4.0

—

(3024932) HLA-DR beta [Type]

240

1.12

0.19

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

385

0.91

0.19

1.5

74.97

76.65

umol/l

0.20

385

(3051593) INR in Capillary blood by Coagulation assay

174

1.15

0.19

9.7

11.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.22

0.19

1.5

1.6

67.83

107.65

ng/l

1.49

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.22

0.19

1.9

1.8

—

(40768793) Breast Pathology biopsy report

127

1211

1.05

0.18

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.23

0.18

1.3

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.21

0.18

1.3

1.8

217.14

174.52

mmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

174

0.86

0.18

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

502

1.07

0.17

1.5

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

330

0.91

0.17

1.0

1.1

86.54

92.60

0.62

263

(3008536) Aspergillus sp Ab [Presence] in Serum

110

1.18

0.17

2.6

2.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

271

2781

0.97

0.17

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.22

0.17

1.3

1.4

27.60

24.34

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

339

1.09

0.17

1.7

1.6

—

(3005033) Fetal Nuchal fold Thickness US

263

2699

0.97

0.16

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

378

1.08

0.16

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

206

1.12

0.15

2.6

1.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.14

0.15

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

389

0.92

0.15

1.3

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

388

0.93

0.14

1.1

1.3

1.46

1.56

g/l

1.26

388

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

311

3038

1.02

0.14

2.6

2.9

34.24

42.55

u/ml

0.71

300

2938

(3032057) Clostridioides difficile [Presence] in Stool

0.83

0.13

2.3

2.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

106

0.85

0.13

1.2

1.5

49.12

23.71

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

265

2704

0.98

0.12

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

189

0.90

0.12

2.5

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

590

1.05

0.11

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

688

1.05

0.11

1.2

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

327

1.07

0.11

3.5

3.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

211

1.09

0.10

1.7

2.5

123.92

130.99

ng/l

0.09

155

(3006462) Nitrate [Presence] in Urine

269

0.93

0.10

1.9

2.7

—

(3022621) pH of Urine by Test strip

363

3680

0.98

0.10

2.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

109

1056

1.03

0.10

1.1

131.44

9388.19

iu/ml

0.63

288

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

251

1.07

0.09

1.2

1.3

12.81

12.09

u/l

0.16

233

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

359

1.06

0.09

1.1

0.12

6.00

nmol/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

184

1.09

0.09

3.8

3.1

—

(3011648) Oxygen content in Venous blood

481

0.95

0.09

4.2

7.7

11.84

11.20

0.48

481

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

223

1.07

0.08

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

272

1.06

0.08

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

297

0.94

0.08

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

123

0.89

0.08

3.9

6.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

439

0.95

0.08

1.6

1.4

202.08

191.37

pmol/l

0.15

439

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

627

1.04

0.07

1.1

41.61

38.46

mg/l

0.22

525

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.84

0.07

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

265

2608

1.01

0.07

2.7

0.65

0.26

e6/l

1.59

255

2516

(3024869) Neuronal Ab [Presence] in Serum

1.08

0.07

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

681

0.97

0.07

1.5

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.07

0.07

1.0

1.2

20.60

40.90

mg/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

112

0.89

0.07

1.0

1.3

—

(40768446) Kidney Pathology biopsy report

265

0.94

0.07

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.83

0.07

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

376

0.96

0.06

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

373

1.04

0.06

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

373

1.04

0.06

1.5

1.7

—

(40765096) Chromosome analysis panel by Banding

152

0.92

0.06

1.0

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

100

0.90

0.06

23.9

14.5

0.32

0.42

umol/l

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

102

0.88

0.06

1.2

2.1

2.31

2.93

nmol/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

668

0.97

0.06

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

278

2744

1.01

0.06

1.5

1.6

4.62

4.05

mg/l

0.33

203

1935

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

207

1.06

0.06

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

207

1.06

0.06

1.5

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

475

0.97

0.05

4.0

3.4

51.79

55.17

0.55

405

(3020876) Protein [Mass/time] in 24 hour Urine

485

0.97

0.05

2.7

2.5

1.70

1.51

g/24h

0.20

257

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

1.08

0.05

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

100

1.10

0.05

1.5

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

120

0.92

0.05

1.4

1.1

—

(3045788) Cell count panel - Pleural fluid

362

0.97

0.04

1.3

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

744

0.98

0.04

1.5

2.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.10

0.04

1.3

2.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

101

1.09

0.04

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

662

0.98

0.03

1.5

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

379

1.03

0.03

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

148

0.94

0.02

1.4

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

608

1.02

0.02

1.0

1.1

224.93

236.20

mg/l

0.21

534

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

660

0.98

0.02

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

359

0.97

0.02

5.9

6.8

—

(3016750) Collection duration of Urine

268

0.97

0.02

2.4

2.2

522.50

497.30

min

0.87

202

(3000034) Microalbumin [Mass/volume] in Urine

428

0.98

0.02

2.5

3.0

19.26

53.87

mg/l

1.30

320

(3025468) Yersinia sp identified in Specimen by Organism specific culture

658

0.99

0.01

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

113

1.06

0.01

1.1

1.4

—

(40768804) Tissue Pathology biopsy report

2288

22863

1.00

0.01

2.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

322

1.02

0.01

1.1

33.14

10.48

u/ml

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

322

1.02

0.01

1.2

1.4

405.94

344.56

u/l

0.26

312

(3014051) Protein [Presence] in Urine by Test strip

149

1497

0.99

0.01

2.0

2.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

667

0.99

0.01

1.5

1.4

—

(3035880) pH of Pleural fluid

193

1.03

0.01

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

243

1.03

0.01

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

366

0.98

0.01

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

134

1.04

0.00

2.2

—

(4281824) Cell count and differential, peritoneal fluid

515

0.99

0.00

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

108

1.02

0.00

3.5

4.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

247

1.01

0.00

1.2

1.1

113.80

390.31

ng/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

125

0.96

0.00

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

480

1.00

0.00

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

135

0.96

0.00

3.5

6.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

181

0.99

0.00

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

181

0.99

0.00

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

181

0.99

0.00

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

193

0.98

0.00

3.0

2.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

116

1.03

0.00

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

116

1.03

0.00

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

116

1.03

0.00

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

116

1.03

0.00

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

948

1.00

0.00

1.5

—

(3006270) Folate [Moles/volume] in Blood

449

1.00

0.00

1.1

410.33

388.90

nmol/l

0.29

404

(3017704) Immunofixation for Urine

227

1.01

0.00

1.7

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.00

0.00

2.0

1.4

13.54

18.99

pmol/l

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

-0.00

0.0

3.6

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

52.33

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.97

-0.00

6.7

5.3

23.29

47.61

ug/min

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.0

—

(3000285) Sodium [Moles/volume] in Blood

1.00

-0.00

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.93

-0.00

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1663.33

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.40

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

7.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.02

-0.00

1.4

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

1.02

-0.00

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.93

-0.00

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.01

-0.00

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.94

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_D07AA – D07AA Corticosteroids, weak (group I)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

D07AA Corticosteroids, weak (group I)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for D07AA Corticosteroids, weak (group I) (RX_D07AA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints